CINXE.COM

<!DOCTYPE html> <html lang="en-us" class="cdc-2022 theme-indigo cdc-tp5" > <head> <meta charset="utf-8" /> <meta http-equiv="X-UA-Compatible" content="IE=Edge" /> <meta content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport" /> <meta name="mobile-web-app-capable" content="yes" /> <meta name="apple-mobile-web-app-capable" content="yes" /> <meta name="theme-color" content="#075290"> <link rel="apple-touch-icon" sizes="180x180" href="/TemplatePackage/4.0/assets/imgs/favicon/apple-touch-icon.png"> <link rel="icon" type="image/png" sizes="32x32" href="/TemplatePackage/4.0/assets/imgs/favicon/favicon-32x32.png"> <link rel="icon" type="image/png" sizes="16x16" href="/TemplatePackage/4.0/assets/imgs/favicon/favicon-16x16.png"> <link rel="mask-icon" href="/TemplatePackage/4.0/assets/imgs/favicon/safari-pinned-tab.svg" color="#0056b3"> <meta name="msapplication-TileColor" content="#0056b3"> <meta name="theme-color" content="#0056b3"> <link rel="stylesheet prefetch" href="/TemplatePackage/contrib/libs/bootstrap/latest/css/bootstrap.min.css?_=82471" /> <link rel="stylesheet prefetch" href="/TemplatePackage/4.0/assets/css/app.tp5.min.css?_=82471" /> <link rel="stylesheet" media="print" href="/TemplatePackage/4.0/assets/css/print.min.css?_=82471" />  <script src="https://www.cdc.gov/JScript/metrics/topic_levels.js?_=82471"></script> <script src="https://www.cdc.gov/JScript/metrics/adobe/launch/b36c1852e229/2c674008a127/launch-04da70ea688d.min.js" async></script> <title>Treatment for Opioid Use Disorder: Population Estimates — United States, 2022 | MMWR</title> <meta name="description" content="This report describes treatment for opioid use disorder (OUD) during 2022. "/> <meta property="og:title" content="Treatment for Opioid Use Disorder: Population ..."> <meta property="og:description" content="This report describes treatment for opioid use disorder (OUD) during 2022."> <meta property="fb:app_id" content="205691699516606"> <meta property="og:url" content="https://www.cdc.gov/mmwr/volumes/73/wr/mm7325a1.htm"> <meta property="og:image" content="https://www.cdc.gov/mmwr/volumes/73/wr/social-media/mm7325a1_OUDTreatment_IMAGE_27JUNE24_1200x675.png?_=11762"> <meta property="og:image:type" content="image/png"> <meta property="article:published_time" content="2024-06-27"> <meta property="og:author" content="CDC"> <meta property="article:author" content="CDCMMWR"> <meta property="og:site_name" content="Centers for Disease Control and Prevention"> <meta property="og:type" content="article"> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="@CDCMMWR"> <meta name="twitter:creator" content="@CDCgov"> <meta name="twitter:title" content="Treatment for Opioid Use Disorder: Population ..."> <meta name="twitter:description" content="This report describes treatment for opioid use disorder (OUD) during 2022."> <meta name="twitter:domain" content="https://www.cdc.gov/mmwr/volumes/73/wr/mm7325a1.htm?s_cid=mm7325a1_w"> <meta name="twitter:image:src" content="https://www.cdc.gov/mmwr/volumes/73/wr/social-media/mm7325a1_OUDTreatment_IMAGE_27JUNE24_1200x675.png?_=11762"> <meta name="robots" content="index, archive" /> <meta property="cdc:template_version" content="4.0"/> <meta property="cdc:first_published" content="June 27, 2024"/> <meta property="cdc:last_updated" content="June 27, 2024, 01:00 PM"/> <meta property="cdc:last_reviewed" content="June 27, 2024"/> <meta property="cdc:content_source" content="DEPUTY DIRECTOR FOR PUBLIC HEALTH SCIENCE AND SURVEILLANCE"/> <meta property="cdc:maintained_by" content="DEPUTY DIRECTOR FOR PUBLIC HEALTH SCIENCE AND SURVEILLANCE"/> <meta property="cdc:content_id" content="112997" /> <meta property="cdc:build" content="3630" /> <meta property="cdc:version" content="4.24.5" /> <meta property="cdc:page_type" content="cdc_mmwr" /> <meta property="cdc:page_origin" content="wcms"/> <meta name="citation_categories" content="Full Report"/><meta name="citation_title" content="Treatment for Opioid Use Disorder: Population Estimates — United States, 2022"/><meta name="citation_author" content="Deborah Dowell"/><meta name="citation_publication_date" content="2024"/><meta name="citation_journal_title" content="MMWR. Morbidity and Mortality Weekly Report"/><meta name="citation_journal_abbrev" content="MMWR Morb Mortal Wkly Rep"/><meta name="citation_issn" content="0149-21951545-861X"/><meta name="citation_volume" content="73"/><meta name="citation_doi" content="10.15585/mmwr.mm7325a1"/><meta name="Description" content="This report describes treatment for opioid use disorder (OUD) during 2022. "/> <link rel="canonical" href="https://www.cdc.gov/mmwr/volumes/73/wr/mm7325a1.htm"/> <meta property="cdc:wcms_build" content="4.24.5 - b.3630" /> <link rel="stylesheet" type="text/css" href="/mmwr/volumes/wcms-inc/local.css?v=3257"/>  <meta name="DC.date" content="2024-06-28T04:12:14Z" /> <meta name="cdc:last_published" content="2024-06-28T16:13:09Z" /> </head> <body class="no-js cdc-mmwr"> <div id="skipmenu"> <a class="skippy sr-only-focusable" href="#content">Skip directly to site content</a> <a class="skippy sr-only-focusable" href="#headerSearch">Skip directly to search</a> </div> <div class="header-language-bar container text-right pt-1 pb-1 fs0875"> <a href="/spanish/"><span lang="es-us">Español</span></a><span class="link-divider"> | </span> <a href="https://wwwn.cdc.gov/pubs/other-languages/">Other Languages</a> </div> <script src="/TemplatePackage/5.0/js/modules/banner.js?v2"></script> <div class="cdc-header-official-notice container noindex"> <div class="cdc-header-official-notice-header d-flex"> <img src="/TemplatePackage/4.0/assets/imgs/uswds/us_flag_small.png" width="16" height="11" alt="U.S. flag" /> <small class="ml-2">An official website of the United States government <button class="cdc-header-official-notice-header-btn">Here's how you know <span class="cdc-header-official-notice-header-icon x12 fill-p cdc-icon-arrow-down"></span></button></small> </div> <div class="cdc-header-official-notice-body row" style="display: none;"> <figure class="col-lg-6 d-flex"> <img class="cdc-header-official-notice-body-img" src="/TemplatePackage/4.0/assets/imgs/uswds/icon-dot-gov.svg" alt="Official icon" aria-hidden="true" /> <figcaption class="cdc-header-official-notice-body-info ml-3"> <p class="cdc-header-official-notice-body-title mb-1"><strong>Official websites use .gov</strong></p> <p>A .gov website belongs to an official government organization in the United States.</p> </figcaption> </figure> <figure class="col-lg-6 d-flex"> <img class="cdc-header-official-notice-body-img" src="/TemplatePackage/4.0/assets/imgs/uswds/icon-https.svg" alt="Lock icon" aria-hidden="true" /> <figcaption class="cdc-header-official-notice-body-info ml-3"> <p class="cdc-header-official-notice-body-title mb-1"><strong>Secure .gov websites use HTTPS</strong></p> <p>A lock ( <span class="x16 fill-black cdc-icon-lock-alt-solid"></span> ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.</p> </figcaption> </figure> </div> </div> <header id="page_banner" role="banner" aria-label="Banner"> <div class="container-fluid header-wrapper"> <div class="container"> <div class="row py-2"> <div class="col cdc-logo"> <a href="https://www.cdc.gov/"> <span class="sr-only">Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People</span> <img src="/TemplatePackage/4.0/assets/imgs/logo/logo-notext.svg" alt="CDC Logo" class="cdc-logo--desktop"> <img src="/TemplatePackage/4.0/assets/imgs/logo/logo-notext.svg" alt="CDC Logo" class="cdc-logo--mobile"> </a> </div> <div class="col-2 col-md-3 col-xl-5 col-xxl-4 tp-search"> <div class="headerSearch cdc-header-search"> <form accept-charset="UTF-8" action="https://search.cdc.gov/search/" class="cdc-header-search-form" method="get" autocomplete="off">  <button class="btn btn-primary dropdown-toggle no-toggle search-button ssi d-xl-none" type="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" aria-label="search"><span>Search</span> <i class="fi cdc-icon-magnify dropdown-menu-medium-search-icon x24" aria-hidden="true"></i> <i class="fi cdc-icon-close dropdown-menu-medium-close-icon x24" aria-hidden="true"></i> </button> <div class="dropdown-menu dropdown-menu-right dropdown-menu-search dropdown-menu-medium-search"> <div class="input-group"> <input id="headerSearch" type="text" class="form-control" maxlength="300" placeholder="Search" aria-label="Search" name="query"> <span class="form-control-clear cdc-icon-close"></span> <div class="input-group-append"> <button class="btn search-submit" type="button"> <span class="sr-only">Submit</span> <i class="fi cdc-icon-magnify x24 search-submit" aria-hidden="true"></i> </button> </div> </div> </div> <input type="hidden" name="affiliate" value="cdc-main"> </form> </div> </div> </div> </div> </div> <div class="container-fluid site-title"> <div class="container"> <div class="row"> <div class="col"> <div class="display-6 text-white fw-500 pt-1 pb-1 site-title-inner "> <a href="/mmwr/index.html"> Morbidity and Mortality Weekly Report (<em>MMWR</em>)</a> </div> </div> </div> </div> </div> <nav role="navigation" aria-label="Mobile Nav" id="mobilenav" class="sticky-top"> </nav>  <div class="container-fluid feature-area"> <div class="container"></div> </div> </header> <div class="container d-flex flex-wrap body-wrapper bg-white"> <main class="col-12 order-lg-2" role="main" aria-label="Main Content Area"> <div class="row visual-element"> <div class="col"> </div> </div> <div class="section-nav-area"> <nav role="navigation" aria-label="Section Nav" class="w-100 sticky-top"></nav> </div> <div class="row"> <div class="col content content-fullwidth"> <h1>Treatment for Opioid Use Disorder: Population Estimates — United States, 2022</h1> <div class="dateline"> <p><em>Weekly</em> / June 27, 2024 / 73(25);567–574 </p> </div> <div class="title-bar"> <a href="#print" class="print-link" aria-label="print this page" onclick="window.print()">Print</a> </div> <div class="mb-3 card tp-related-pages fourth-level-nav d-none"> <div class="card-header collapse-icon"> <a class="collapse-link float-right nav-minus fs0875" data-toggle="collapse" href="#collapse_112997667ee115309f4" aria-expanded="false" aria-controls="collapse_112997667ee115309f4"> <svg viewBox="0 0 24 24" focusable="false" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <title>Minus</title> <path d="M19,13H5V11H19V13Z"></path> </svg> </a> <div class="h4">Related Pages</div> </div> <div class="card-body collapse show" id="collapse_112997667ee115309f4"></div> </div> <div class="syndicate"> <div class="d-flex flex-wrap d-md-block"> <div class="order-3 mb-3"><p>Deborah Dowell, MD<sup>1</sup>; Samantha Brown, MPH<sup>2</sup>; Shiromani Gyawali, MS<sup>2</sup>; Jennifer Hoenig, PhD<sup>2</sup>; Jean Ko, PhD<sup>1</sup>; Christina Mikosz, MD<sup>1</sup>; Emily Ussery, PhD<sup>1</sup>; Grant Baldwin, PhD<sup>1</sup>; Christopher M. Jones, DrPH<sup>2</sup>; Yngvild Olsen, MD<sup>2</sup>; Naomi Tomoyasu, PhD<sup>2</sup>; Beth Han, MD, PhD<sup>3</sup>; Wilson M. Compton, MD<sup>3</sup>; Nora D. Volkow, MD<sup>3</sup> (<a class="h6" style="font-weight: normal" href="#contribAff">View author affiliations</a>)</p> <a class="mb-md-3" href="#suggestedcitation">View suggested citation</a></div><div class="bg-gray-l2 col-md-9 float-left mb-3 order-0 "><h3><strong>Summary</strong></h3> <p><strong>What is already known about this topic?</strong></p> <p>Although medications for opioid use disorder (OUD) substantially reduce mortality, they are underused.</p> <p><strong>What is added by this report?</strong></p> <p>In 2022, among the 4% of U.S. adults who needed OUD treatment, only 25% received recommended medications. A larger percentage (30%) received treatment without medications. Higher percentages of White than Black or African American or Hispanic or Latino adults received any treatment. Higher percentages of men than women and of adults aged 35–49 years than other adults received medications.</p> <p><strong>What are the implications for public health practice?</strong></p> <p>Expanded communication about the effectiveness of medications for OUD is needed. Clinicians and other treatment providers should offer or arrange evidence-based treatment, including medications for OUD. Pharmacists and payors can support making these medications available without delays.</p> </div><div class="col-md-3 float-right order-12 mt-3 mt-md-0 no-syndicate "> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script async src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script> <style type="text/css"> .altmetric-embed.mt-2.mb-3 > div { display: flex; } </style> <div class="card mb-3" data-mmwr-metrics="article"> <div class="card-header h4 bg-primary">Article Metrics</div> <div class="card-body bg-white"> <h5>Altmetric:</h5> <div class="altmetric-embed mt-2 mb-3" data-badge-details="right" data-badge-type="donut" data-condensed="true" data-hide-no-mentions="true" data-link-target="_blank"></div> <div class="text-right"></div> </div> <div class="border-top mt-2 mb-3"></div> <div class="ml-2"> <span class="__dimensions_badge_embed__" data-doi="10.15585/mmwr.mm7325a1" data-legend="always" data-style="small_circle"></span><script async src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script> <br> </div> </div> </div><div class="col-md-3 float-right d-none d-md-block cr mb-3"><div class="card theme-cyan bg-gray-l2"><div class="card-header"><a href="#F1_down"><strong>Figure</strong></a></div></div></div><div class="col-md-3 float-right d-none d-md-block cr mb-3"><div class="card theme-cyan bg-gray-l2"><div class="card-header"><a href="#T1_down"><strong>Table</strong></a></div></div></div><div class="col-md-3 float-right mb-3 cr order-1"><div class="card mb-3"><div class="card-header h4 bg-primary">Related Materials</div><div class="card-body"><ul class="mb-0 block-list"><li><a href="/mmwr/volumes/73/wr/pdfs/mm7325a1-H.pdf" target="_blank">Article PDF<span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf x16 fill-pdf" alt="" aria-hidden="true"></span><span class="file-details"></span></a></li><li><a href="/mmwr/volumes/73/wr/pdfs/mm7325-H.pdf" target="_blank">Full Issue PDF<span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf x16 fill-pdf" alt="" aria-hidden="true"></span><span class="file-details"></span></a></li><li><a href="https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.11977" class="tp-link-policy" data-domain-ext="com">Major gaps in the cascade of care for opioid use disorder: implications for clinical practice<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li></ul></div></div></div><div class="order-4 w-100"><div class="mb-3"><img decoding="async" class="img-fluid" alt="The graphic has text that reads, “Only 1 in 4 adults who need opioid use disorder (OUD) treatment receive medications for OUD” with a picture of a person with their arms crossed and an image of two pharmacists in a pharmacy." title="Treatment for Opioid Use Disorder: Population Estimates — United States, 2022" src="/mmwr/volumes/73/wr/social-media/mm7325a1_OUDTreatment_IMAGE_27JUNE24_1200x675-medium.png?_=11762"><div class="liv"><div class="pt-2 mb-2"><a data-target="#modalIMG112997667ee11579d31" data-toggle="modal" href="#"><span aria-label="resize icon" class="sr-only" role="img"></span><span class="fi cdc-icon-resize icon x20 align-top mr-2" alt="" aria-hidden="true"></span>View Larger</a></div></div><div aria-hidden="true" aria-label="Large Image" class="modal large-img fade" id="modalIMG112997667ee11579d31" role="dialog" tabindex="-1"><div class="modal-dialog modal-image-enlargement" role="document"><div class="modal-content "><button type="button" class="close rounded-circle" data-dismiss="modal" aria-label="Close" style="width: 34px;height:34px;margin-top:0px;"><span class="sr-only">Close</span><span class="fi cdc-icon-close x24" aria-hidden="true"></span></button><div class="modal-body"><img decoding="async" class="img-fluid" alt="The graphic has text that reads, “Only 1 in 4 adults who need opioid use disorder (OUD) treatment receive medications for OUD” with a picture of a person with their arms crossed and an image of two pharmacists in a pharmacy." style="width:100% !important;" title="Treatment for Opioid Use Disorder: Population Estimates — United States, 2022" src="/mmwr/volumes/73/wr/social-media/mm7325a1_OUDTreatment_IMAGE_27JUNE24_1200x675-medium.png?_=11762"></div><div class="modal-footer fj-start bg-gray-l3"><span aria-label="download icon" class="sr-only" role="img"></span><span class="fi cdc-icon-download_01 icon x20 align-top mr-2 fill-blue-p" alt="" aria-hidden="true"></span><a href="/mmwr/volumes/73/wr/social-media/mm7325a1_OUDTreatment_IMAGE_27JUNE24_1200x675-medium.png?_=11762?noicon" target="_blank" rel="noopener noreferrer" class="mr-2 text-blue">Download Image</a>[PNG]</div></div></div></div></div> <div> <h2><a id="abstract" class="onThisPageAnchor" title="Abstract"></a>Abstract</h2> <p>In 2022, 81,806 opioid-involved overdose deaths were reported in the United States, more than in any previous year. Medications for opioid use disorder (OUD), particularly buprenorphine and methadone, substantially reduce overdose-related and overall mortality. However, only a small proportion of persons with OUD receive these medications. Data from the 2022 National Survey on Drug Use and Health were applied to a cascade of care framework to estimate and characterize U.S. adult populations who need OUD treatment, receive any OUD treatment, and receive medications for OUD. In 2022, 3.7% of U.S. adults aged ≥18 years needed OUD treatment. Among these, only 25.1% received medications for OUD. Most adults who needed OUD treatment either did not perceive that they needed it (42.7%) or received OUD treatment without medications for OUD (30.0%). Compared with non-Hispanic Black or African American and Hispanic or Latino adults, higher percentages of non-Hispanic White adults received any OUD treatment. Higher percentages of men and adults aged 35–49 years received medications for OUD than did women and younger or older adults. Expanded communication about the effectiveness of medications for OUD is needed. Increased efforts to engage persons with OUD in treatment that includes medications are essential. Clinicians and other treatment providers should offer or arrange evidence-based treatment, including medications, for patients with OUD. Pharmacists and payors can work to make these medications available without delays.</p> </div> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><div> <h2><a id="introduction" class="onThisPageAnchor" title="Introduction"></a>Introduction</h2> <p>In 2022, more opioid-involved overdose deaths (81,806) were reported in the United States than in any previous year.* Medications for opioid use disorder (OUD) include buprenorphine, methadone, and extended-release naltrexone. These medications, especially buprenorphine and methadone, substantially reduce overdose-related and overall mortality but are markedly underused (<i>1</i>,<i>2</i>). Using an OUD cascade of care framework adapted from HIV care delivery improvement efforts (<i>2</i>), National Survey on Drug Use and Health (NSDUH) data were used to estimate and characterize U.S. adult populations who 1) need OUD treatment, 2) perceive a need for OUD treatment, 3) receive any OUD treatment, and 4) receive medications for OUD.</p> </div> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><div> <h2><a id="methods" class="onThisPageAnchor" title="Methods"></a>Methods</h2> <h3 class="h3">Data Source</h3> <p>NSDUH collects substance use and substance use disorder (SUD) treatment information through in-person and web-based interviews among a nationally representative sample of civilian, noninstitutionalized persons aged ≥12 years in the United States.<sup>&dagger;</sup> Data from 56,610 adults aged ≥18 years (weighted interview response rate = 48.0%) participating in the 2022 NSDUH were analyzed to estimate numbers and percentages of adults who needed OUD treatment, perceived a need for OUD treatment, received any OUD treatment, and received medications for OUD in the past year.</p> <h3 class="h3">Definitions</h3> <p>The <i>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition</i> (DSM-5)<sup>§</sup> describes OUD as “a problematic pattern of opioid use leading to clinically significant impairment or distress.” Needing OUD treatment was defined as meeting DSM-5 criteria for mild or moderate OUD (two to five symptoms) or severe OUD (six or more symptoms) or receiving OUD treatment during the preceding year. Persons receiving OUD treatment without meeting OUD criteria in the preceding year were assumed to have had an active OUD (i.e., to have had symptoms meeting criteria for OUD) in the past and to have successfully treated OUD with continued treatment. Respondents needing but not reporting OUD treatment in the previous year were asked whether they sought or thought they should receive OUD treatment; affirmative responses were coded as perceiving need for treatment. Receipt of OUD treatment was defined as receiving treatment for OUD or receiving treatment for an unspecified SUD along with reporting opioid use, with the assumption that the unspecified SUD was OUD. Receipt of medications for OUD was defined as taking medication in the past year prescribed to help reduce or stop opioid use (e.g., buprenorphine, methadone, or naltrexone).</p> <h3 class="h3">Statistical Analysis</h3> <p>Weighted prevalence estimates and 95% CIs were calculated overall and by sociodemographic-, health-, and substance-related characteristics. Log-linear chi-square tests of independence assessed overall differences between subgroups, followed by pairwise comparisons using <i>t</i>-tests. Analyses were conducted using SAS-callable SUDAAN (version 11.0; RTI International) to account for NSDUH’s complex design and sampling weights. This activity was reviewed by CDC, deemed not research, and conducted consistent with applicable federal law and CDC policy.<sup>¶</sup></p> </div> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><div> <h2><a id="results" class="onThisPageAnchor" title="Results"></a>Results</h2> <p>In 2022, an estimated 3.7% of U.S. adults (9,367,000) needed OUD treatment (<a id="F1_up"></a><a href="#F1_down">Figure</a>) (<a id="T1_up"></a><a href="#T1_down">Table</a>). Among these, 55.2% (5,167,000) received OUD treatment, and 25.1% (2,353,000) received medications for OUD (Figure). Most adults who needed OUD treatment either did not perceive that they needed it (42.7%) or received treatment that did not include medications for OUD (30.0%) (Figure).</p> <h3 class="h3">Need for OUD Treatment</h3> <p>The percentage of adults aged 18–25 years who needed OUD treatment (2.2%) was lower than that among older age groups (range = 3.7%–4.3%) (Table). Groups in which a high percentage of persons needed OUD treatment included those who did not attend college (4.9%), were not employed (5.2%), or had ever been arrested and booked (9.7%). Need for OUD treatment increased with poverty level: it was lowest (2.5%) among those with income ≥200% of the federal poverty level [FPL], increasing to 5.0% among those with income 100%–199% of FPL, and was highest (7.5%) among persons with income <100% of FPL. The percentage of adults who needed OUD treatment was elevated among those who, during the previous year, had any mental illness (9.0%), used illicit drugs other than opioids** (7.6%) or marijuana (7.0%), misused stimulants<sup>&dagger;&dagger;</sup> (20.7%) or opioids<sup>§§</sup> (35.9%), or had a nonopioid SUD (10.4%).</p> <h3 class="h3">OUD Treatment</h3> <p>The percentage of adults needing OUD treatment who received treatment was lower among those aged ≥50 years (44.9%) than among younger age groups (range = 58.9%–67.8%) (Table). The percentage of adults who received treatment was higher among non-Hispanic White (White) adults (60.3%) than among non-Hispanic Black or African American (Black) (43.8%) or Hispanic or Latino (Hispanic) (45.7%) adults and among adults with severe OUD (53.0%) than among those with mild or moderate OUD (20.5%). Compared with other adults, the percentage who received OUD treatment was higher among those who were employed (63.1%), had ever been arrested and booked (66.3%), or had used illicit drugs other than opioids (61.2%).</p> <h3 class="h3">Receipt of Medications for OUD</h3> <p>Among adults who needed and received any OUD treatment, fewer than one half (45.5%) received medications for OUD. The percentage of adults who received medications for OUD was higher among those who were employed (52.5%), were ever arrested and booked (63.0%), used illicit drugs other than opioids (52.9%), used marijuana (53.1%), misused stimulants (59.4%), misused opioids (61.7%), or had a past-year SUD involving a substance other than opioids (51.8%), than among those without these characteristics or exposures. The percentage who received medications for OUD was higher for men (51.0%) than for women (39.5%), for those aged 35–49 years (68.4%) than for those in other age groups (18–25 = 19.9%; 26–34 = 44.1%; ≥50 = 32.3%), and for those with severe OUD (80.7%) than for those with mild or moderate OUD (55.5%).</p> </div> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><div> <h2><a id="discussion" class="onThisPageAnchor" title="Discussion"></a>Discussion</h2> <p>Among adults needing OUD treatment in 2022, only 25% received medications for OUD; 30% received OUD treatment not including these medications. These findings underscore disparities in treatment and a need to increase use of medications for OUD. Lower percentages of Black and Hispanic adults, who have been particularly affected by increasing overdose deaths (<i>3</i>), received any OUD treatment compared with White adults. Among adults who received OUD treatment, lower percentages of women and younger and older adults received medication. Higher proportions of persons with other drug use or misuse or who had ever been arrested and booked received medications for OUD; these findings might reflect greater awareness of treatment need or contact with systems linking persons to OUD treatment. Higher percentages receiving medication among adults with severe OUD might reflect perception or more clinician recognition of treatment need among adults with six or more OUD symptoms. Still, among adults with severe OUD, fewer than one half (80.7% of the 53.0% who received any OUD treatment) received medications for OUD, underscoring the large gap in receipt of evidence-based treatment, even for this highly affected group.</p> <p>Approximately 43% of adults needing OUD treatment did not perceive that they needed it, consistent with previous findings that large proportions of persons with SUDs did not feel that they needed treatment.<sup>¶¶</sup> Patients taking opioids only as prescribed (who constitute a majority of persons meeting OUD criteria***) might be particularly unlikely to perceive a need for OUD treatment, even if they experience OUD symptoms. If clinicians suspect that patients prescribed opioids for pain have OUD on the basis of patient concerns or behaviors, or if patients experience harm from opioids or choose to but are unable to taper opioids, clinicians should discuss their concern with the patient, provide an opportunity for the patient to disclose related concerns or problems, and assess for OUD using DSM-5 criteria (<i>4</i>). Nonjudgmental support and harm reduction approaches can establish rapport, build trust, and reduce overdoses and other harms among persons not ready for treatment.<sup>&dagger;&dagger;&dagger;</sup></p> <p>Several factors limit access to medications for OUD despite strong recommendations for their use (<i>4</i><i>,</i><i>5</i>). Some clinicians prefer an approach that does not include medications, and some hold beliefs equating medications for OUD with illegal substance use (<i>6</i>). Methadone for OUD can only be dispensed from a Substance Abuse and Mental Health Services Administration–certified opioid treatment program (OTP); many U.S. counties have no OTP.<sup>§§§</sup> Buprenorphine or naltrexone can be prescribed in any setting, but several barriers exist. Many facilities treating OUD do not offer these medications; some do not accept clients using medications for OUD.<sup>¶¶¶</sup> In addition, large proportions of pharmacies do not stock buprenorphine.**** Payors, including many state Medicaid programs, have restrictions (such as prior authorization) that can delay dispensing of some buprenorphine formulations (<i>7</i>). Fewer than 10% of physicians<sup>&dagger;&dagger;&dagger;&dagger;</sup> obtained the waiver that, until 2023, was required to prescribe buprenorphine for OUD. Primary care physicians have reported barriers to obtaining the waiver and prescribing buprenorphine, including too little experience treating OUD, concern about being inundated with requests for buprenorphine, lack of access to addiction or behavioral health specialists, and acquiring the training required to obtain a waiver (<i>8</i>).</p> <h3 class="h3">Limitations</h3> <p>The findings in this report are subject to at least five limitations. First, the number of persons needing OUD treatment presented in this report are likely underestimates; NSDUH is a household survey, includes persons experiencing homelessness only if they use shelters, and does not include residents of institutional group quarters such as jails. Second, NSDUH response rates in 2021 and 2022 were lower than in previous years, which might increase the potential for nonresponse bias resulting in over- or underestimates. Third, sample size limited some comparisons of OUD treatment across racial and ethnic groups, prohibited comparisons across health insurance coverage, and precluded treatment estimates specific to persons with mild OUD or with moderate OUD. Medications for OUD are strongly recommended, particularly for moderate or severe OUD (<i>4</i><i>,</i><i>5</i>). However, Food and Drug Administration approvals for medications for OUD were based on data for patients with opioid dependence as defined by <i>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition</i>; application to DSM-5–defined mild OUD is less clear (<i>5</i>). Understanding specific treatment needs for patients with mild OUD merits further study. Fourth, cross-sectional survey responses were insufficient to ascertain the presence of OUD symptoms before the preceding year. Finally, OUD was a proxy diagnosis based on respondents’ answers to questions corresponding to diagnostic criteria; respondents were not asked whether they had ever received a clinical diagnosis of OUD.</p> <h3 class="h3">Implications for Public Health Practice</h3> <p>The shift from use of heroin to illegally manufactured fentanyl has increased the likelihood that overdoses are fatal (<i>9</i>), adding urgency to the need to provide effective care for persons with OUD (<i>2</i>). This need is particularly acute for Black and Hispanic adults (<i>3</i>,<i>10</i>), women, and younger and older adults. Population-level interventions across a variety of settings are needed to link persons to care,<sup>§§§§</sup><sup>,</sup><sup>¶¶¶¶</sup> initiate medications for OUD,***** and support sustained treatment and recovery.</p> <p>Expanded communication about effectiveness of medications for OUD is needed to reduce nonfatal and fatal overdoses. Increasing awareness among persons who use drugs and their families, friends, and other contacts that medications for OUD are effective is critical.<sup>&dagger;&dagger;&dagger;&dagger;&dagger;</sup> Clinicians and treatment providers should offer or arrange evidence-based treatment, including medications for OUD (<i>4</i>). As of 2023, a waiver is no longer required to prescribe buprenorphine. All clinicians with a current Drug Enforcement Administration registration including Schedule III authority may prescribe buprenorphine for OUD if permitted by applicable state law.<sup>§§§§§</sup> Guidance (<i>4</i>,<i>5</i>) and mentoring<sup>¶¶¶¶¶</sup> are available for diagnosis and management of opioid use disorder. Pharmacists and payors can work to make these life-saving medications available without delays.</p> </div> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><hr style="border-top:1px solid"><div class="order-4 w-100"><p>Corresponding author: Deborah Dowell, ddowell@cdc.gov.</p> <p><sup>1</sup>Division of Overdose Prevention, National Center for Injury Prevention and Control, CDC; <sup>2</sup>Substance Abuse and Mental Health Services Administration, Rockville, Maryland; <sup>3</sup>National Institute on Drug Abuse, Bethesda, Maryland.</p> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><div class="footnote-text"> <p class="Footnote">All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Wilson M. Compton reports ownership of stock in General Electric Company (sold September 2022), 3M companies, and Pfizer, Inc. Yngvild Olsen reports providing medical care to patients with opioid use disorder as an approved, part-time (4 hours per week) external activity to her work at the Substance Abuse and Mental Health Services Administration. No other potential conflicts of interest were reported.</p> </div> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><br><div class="order-4 w-100"><div class="footnote-text"> <p class="Footnote">* <a href="https://www.cdc.gov/nchs/data/databriefs/db491-tables.pdf" target="_blank">https://www.cdc.gov/nchs/data/databriefs/db491-tables.pdf<span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf x16 fill-pdf" alt="" aria-hidden="true"></span><span class="file-details"></span></a></p> <p class="Footnote"><sup>&dagger;</sup> <a href="https://www.samhsa.gov/data/report/nsduh-2022-methodological-resource-book-mrb" class="tp-link-policy" data-domain-ext="gov">https://www.samhsa.gov/data/report/nsduh-2022-methodological-resource-book-mrb<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote"><sup>§</sup> <a href="https://dsm.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596" class="tp-link-policy" data-domain-ext="org">https://dsm.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote"><sup>¶</sup> 45 C.F.R. part 46.102(l)(2), 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq.</p> <p class="Footnote">** Illicit drug use other than opioid use includes the use of cocaine, hallucinogens, inhalants, marijuana, or methamphetamine, or misuse of prescription tranquilizers, sedatives, or stimulants.</p> <p class="Footnote"><sup>&dagger;&dagger;</sup> Stimulant misuse includes the use of cocaine or methamphetamine or use of prescription stimulants in any way not directed by a health care professional.</p> <p class="Footnote"><sup>§§</sup> Opioid misuse includes use of heroin or use of prescription pain relievers in any way not directed by a health care professional.</p> <p class="Footnote"><sup>¶¶</sup> <a href="https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR090120.htm" class="tp-link-policy" data-domain-ext="gov">https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR090120.htm<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote">*** <a href="https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report" class="tp-link-policy" data-domain-ext="gov">https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote"><sup>&dagger;&dagger;&dagger;</sup> <a href="https://store.samhsa.gov/product/tip-63-medications-opioid-use-disorder/pep21-02-01-002" class="tp-link-policy" data-domain-ext="gov">https://store.samhsa.gov/product/tip-63-medications-opioid-use-disorder/pep21-02-01-002<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote"><sup>§§§</sup> <a href="https://www.everycrsreport.com/files/20190624_R45782_ed39091fadf888655ebd69729c3180c3f7e550f6.pdf" target="_blank" class="tp-link-policy" data-domain-ext="com">https://www.everycrsreport.com/files/20190624_R45782_ed39091fadf888655ebd69729c3180c3f7e550f6.pdf<span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf x16 fill-pdf" alt="" aria-hidden="true"></span><span class="file-details"></span><span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote"><sup>¶¶¶</sup> <a href="https://www.samhsa.gov/data/sites/default/files/reports/rpt35313/2020_NSSATS_FINAL.pdf" target="_blank" class="tp-link-policy" data-domain-ext="gov">https://www.samhsa.gov/data/sites/default/files/reports/rpt35313/2020_NSSATS_FINAL.pdf<span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf x16 fill-pdf" alt="" aria-hidden="true"></span><span class="file-details"></span><span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote">**** <a href="https://www.samhsa.gov/sites/default/files/policy-priority-roundtable-buprenorphine-access-pharmacies.pdf" target="_blank" class="tp-link-policy" data-domain-ext="gov">https://www.samhsa.gov/sites/default/files/policy-priority-roundtable-buprenorphine-access-pharmacies.pdf<span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf x16 fill-pdf" alt="" aria-hidden="true"></span><span class="file-details"></span><span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote"><sup>&dagger;&dagger;&dagger;&dagger;</sup> <a href="https://aspe.hhs.gov/sites/default/files/documents/facbce1704035fded1034192d148304d/buprenorphine-practice-guideline-early-impacts.pdf" target="_blank" class="tp-link-policy" data-domain-ext="gov">https://aspe.hhs.gov/sites/default/files/documents/facbce1704035fded1034192d148304d/buprenorphine-practice-guideline-early-impacts.pdf<span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf x16 fill-pdf" alt="" aria-hidden="true"></span><span class="file-details"></span><span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote"><sup>§§§§</sup> <a href="https://stacks.cdc.gov/view/cdc/119464">https://stacks.cdc.gov/view/cdc/119464</a></p> <p class="Footnote"><sup>¶¶¶¶</sup> <a href="https://www.cdc.gov/overdose-prevention/php/od2a/prevention.html">https://www.cdc.gov/overdose-prevention/php/od2a/prevention.html</a></p> <p class="Footnote">***** <a href="https://www.samhsa.gov/sites/default/files/grants/pdf/fy-2024-sor-nofo.pdf" target="_blank" class="tp-link-policy" data-domain-ext="gov">https://www.samhsa.gov/sites/default/files/grants/pdf/fy-2024-sor-nofo.pdf<span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf x16 fill-pdf" alt="" aria-hidden="true"></span><span class="file-details"></span><span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote"><sup>&dagger;&dagger;&dagger;&dagger;&dagger;</sup> <a href="https://pcssnow.org/courses/guide-for-families-medications-for-opioid-use-disorder-2/" class="tp-link-policy" data-domain-ext="org">https://pcssnow.org/courses/guide-for-families-medications-for-opioid-use-disorder-2/<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote"><sup>§§§§§</sup> <a href="http://www.samhsa.gov/medications-substance-use-disorders/waiver-elimination-mat-act" class="tp-link-policy" data-domain-ext="gov">www.samhsa.gov/medications-substance-use-disorders/waiver-elimination-mat-act<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> <p class="Footnote"><sup>¶¶¶¶¶</sup> <a href="https://pcssnow.org/mentoring/" class="tp-link-policy" data-domain-ext="org">https://pcssnow.org/mentoring/<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></p> </div> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><h2><a id="References" class="onThisPageAnchor" title="References"></a>References</h2> <ol> <li>Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ 2017;357:j1550. <a href="http://doi.org/10.1136/bmj.j1550" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1136/bmj.j1550<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/28446428" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:28446428<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li> <li>Socías ME, Volkow N, Wood E. Adopting the ‘cascade of care’ framework: an opportunity to close the implementation gap in addiction care? Addiction 2016;111:2079–81. <a href="http://doi.org/10.1111/add.13479" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1111/add.13479<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/27412876" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:27412876<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li> <li>Kariisa M, Davis NL, Kumar S, et al. Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics—25 states and the District of Columbia, 2019–2020. MMWR Morb Mortal Wkly Rep 2022;71:940–7. <a href="http://doi.org/10.15585/mmwr.mm7129e2" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.15585/mmwr.mm7129e2<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/35862289" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:35862289<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li> <li>Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1–95. <a href="http://doi.org/10.15585/mmwr.rr7103a1" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.15585/mmwr.rr7103a1<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/36327391" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:36327391<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li> <li>American Society of Addiction Medicine. The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med 2020;14(Suppl 1):1–91. <a href="http://doi.org/10.1097/ADM.0000000000000633" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1097/ADM.0000000000000633<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/32511106" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:32511106<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li> <li>Madden EF, Prevedel S, Light T, Sulzer SH. Intervention stigma toward medications for opioid use disorder: a systematic review. Subst Use Misuse 2021;56:2181–201. <a href="http://doi.org/10.1080/10826084.2021.1975749" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1080/10826084.2021.1975749<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/34538213" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:34538213<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li> <li>Nguemeni Tiako MJ, Dolan A, Abrams M, Oyekanmi K, Meisel Z, Aronowitz SV. Thematic analysis of state Medicaid buprenorphine prior authorization requirements. JAMA Netw Open 2023;6:e2318487. <a href="http://doi.org/10.1001/jamanetworkopen.2023.18487" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1001/jamanetworkopen.2023.18487<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/37318805" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:37318805<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li> <li>Foti K, Heyward J, Tajanlangit M, et al. Primary care physicians’ preparedness to treat opioid use disorder in the United States: a cross-sectional survey. Drug Alcohol Depend 2021; 225:108811. <a href="http://doi.org/10.1016/j.drugalcdep.2021.108811" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1016/j.drugalcdep.2021.108811<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/34175786" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:34175786<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li> <li>Casillas SM, Pickens CM, Tanz LJ, Vivolo-Kantor AM. Estimating the ratio of fatal to non-fatal overdoses involving all drugs, all opioids, synthetic opioids, heroin or stimulants, USA, 2010–2020. Inj Prev 2024;30:114–24. <a href="http://doi.org/10.1136/ip-2023-045091" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1136/ip-2023-045091<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/38290778" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:38290778<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li> <li>Barnett ML, Meara E, Lewinson T, et al. Racial inequality in receipt of medications for opioid use disorder. N Engl J Med 2023;388:1779–89. <a href="http://doi.org/10.1056/NEJMsa2212412" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">https://doi.org/10.1056/NEJMsa2212412<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/37163624" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="gov">PMID:37163624<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a></li> </ol> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><div class="col-12"></div> <h5 class="h5"><a id="F1_down"></a><a href="#F1_up"><img decoding="async" class="float-right" title="Return to your place in the text" src="//www.cdc.gov/images/arrow_up.gif" alt="Return to your place in the text" width="58" height="34" border="0"></a><b>FIGURE</b>. <strong>Estimated opioid use disorder treatment among adults aged ≥18 years — National Survey on Drug Use and Health, United States, 2022*</strong></h5> <div class="mb-3"><img decoding="async" class="img-fluid" alt="The figure is a flowchart indicating the estimated opioid use disorder treatment among adults aged ≥18 years in the United States during 2022." title="Treatment for Opioid Use Disorder: Population Estimates — United States, 2022" src="/mmwr/volumes/73/wr/figures/mm7325a1-F-large.gif?_=14540"></div> <p><b>Abbreviation:</b> OUD = opioid use disorder.</p> <p>* Needing OUD treatment was defined as meeting <i>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition</i> criteria for OUD or receiving OUD treatment during the past year. Receiving OUD treatment was defined as receiving treatment for opioid use or receiving treatment for an unspecified substance along with reporting opioid use in the past year. Receiving medications for OUD was defined as having used medication in the past year prescribed to help reduce or stop opioid use. Examples of medications shown to respondents included methadone, buprenorphine or buprenorphine-naloxone, injectable buprenorphine, buprenorphine implants, naltrexone pills, and injectable naltrexone. Adults were classified as perceiving need for OUD treatment if they responded affirmatively to questions about whether they thought they should receive or sought drug use treatment in the past year. Numbers are weighted estimates rounded to the nearest thousand. Percentages are numbers (n or N) divided by the overall N (9,367,000) of adults who needed OUD treatment. Percentages are rounded to the nearest tenth and might not sum to 100% because of rounding.</p> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><div class="order-4 w-100"><table class="table table-bordered table-responsive"> <caption class="caption-top h4 text-black" style="text-align: left"><a id="T1_down"></a> <h5><strong>TABLE. Estimated number* and percentage of adults aged ≥18 years who during the past year needed opioid use disorder treatment,<sup>&dagger;</sup> received opioid use disorder treatment,<sup>§</sup> or received medication for opioid use disorder<sup>¶</sup> — National Survey on Drug Use and Health, United States, 2022</strong><a href="#T1_up"><img loading="lazy" decoding="async" class="float-right" title="Return to your place in the text" src="//www.cdc.gov/images/arrow_up.gif" alt="Return to your place in the text" width="58" height="34" border="0"></a></h5> </caption> <thead> <tr> <th class="row1left" rowspan="2" scope="col" align="left" valign="bottom">Characteristic</th> <th class="row1" colspan="2" scope="col" align="center" valign="bottom">Needed OUD treatment<sup>&dagger;</sup></th> <th class="row1" colspan="2" scope="col" align="center" valign="bottom">Received OUD treatment among adults classified as needing OUD treatment<sup>§</sup></th> <th class="row1" colspan="2" scope="col" align="center" valign="bottom">Received medication for OUD among adults who received OUD treatment<sup>¶</sup></th> </tr> <tr> <th class="row1" colspan="1" scope="col" align="center" valign="bottom">Estimated weighted no.*<br> (95% CI)</th> <th class="row1" scope="col" align="center" valign="bottom">% (95% CI)</th> <th class="row1" scope="col" align="center" valign="bottom">Estimated weighted no.* (95% CI)</th> <th class="row1" scope="col" align="center" valign="bottom">% (95% CI)</th> <th class="row1" scope="col" align="center" valign="bottom">Estimated weighted no.* (95% CI)</th> <th class="row1" scope="col" align="center" valign="bottom">% (95% CI)</th> </tr> </thead> <tbody> <tr> <td align="left" valign="bottom"><b><b>Total</b></b></td> <td align="right" valign="bottom"><b><b>9,367 (8,603–10,196)</b></b></td> <td align="right" valign="bottom"><b><b>3.7 (3.4–4.0)</b></b></td> <td align="right" valign="bottom"><b><b>5,167 (4,756–5,571)</b></b></td> <td align="right" valign="bottom"><b><b>55.2 (50.8–59.5)</b></b></td> <td align="right" valign="bottom"><b><b>2,353 (2,077–2,634)</b></b></td> <td align="right" valign="bottom"><b><b>45.5 (40.2–51.0)</b></b></td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Sex</b></b></td> </tr> <tr> <td align="left" valign="bottom">Female</td> <td align="right" valign="bottom">4,623 (4,144–5,154)</td> <td align="right" valign="bottom">3.5 (3.2–3.9)</td> <td align="right" valign="bottom">2,461 (2,207–2,711)</td> <td align="right" valign="bottom">53.2 (47.7–58.6)</td> <td align="right" valign="bottom">971 (813–1,139)</td> <td align="right" valign="bottom">39.5 (33.0–46.3)**</td> </tr> <tr> <td align="left" valign="bottom">Male</td> <td align="right" valign="bottom">4,744 (4,160–5,407)</td> <td align="right" valign="bottom">3.8 (3.3–4.3)</td> <td align="right" valign="bottom">2,706 (2,384–3,016)</td> <td align="right" valign="bottom">57.0 (50.2–63.6)</td> <td align="right" valign="bottom">1,381 (1,156–1,605)</td> <td align="right" valign="bottom">51.0 (42.7–59.3)**</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Age group, yrs</b></b></td> </tr> <tr> <td align="left" valign="bottom">18–25</td> <td align="right" valign="bottom">770 (663–894)</td> <td align="right" valign="bottom">2.2 (1.9–2.6)<sup>&dagger;&dagger;</sup></td> <td align="right" valign="bottom">453 (391–512)</td> <td align="right" valign="bottom">58.9 (50.8–66.5)</td> <td align="right" valign="bottom">90 (62–128)</td> <td align="right" valign="bottom">19.9 (13.7–28.1)<sup>§§</sup></td> </tr> <tr> <td align="left" valign="bottom">26–34</td> <td align="right" valign="bottom">1,534 (1,292–1,818)</td> <td align="right" valign="bottom">3.8 (3.2–4.5)</td> <td align="right" valign="bottom">1,039 (887–1,171)</td> <td align="right" valign="bottom">67.8 (57.8–76.3)</td> <td align="right" valign="bottom">458 (365–555)</td> <td align="right" valign="bottom">44.1 (35.1–53.4)<sup>§§</sup></td> </tr> <tr> <td align="left" valign="bottom">35–49</td> <td align="right" valign="bottom">2,692 (2,359–3,069)</td> <td align="right" valign="bottom">4.3 (3.8–4.9)</td> <td align="right" valign="bottom">1,713 (1,538–1,875)</td> <td align="right" valign="bottom">63.6 (57.1–69.7)</td> <td align="right" valign="bottom">1,171 (1,055–1,275)</td> <td align="right" valign="bottom">68.4 (61.6–74.5)<sup>&dagger;&dagger;</sup></td> </tr> <tr> <td align="left" valign="bottom">≥50</td> <td align="right" valign="bottom">4,371 (3,769–5,065)</td> <td align="right" valign="bottom">3.7 (3.2–4.3)</td> <td align="right" valign="bottom">1,962 (1,645–2,288)</td> <td align="right" valign="bottom">44.9 (37.6–52.3)<sup>&dagger;&dagger;</sup></td> <td align="right" valign="bottom">633 (442–860)</td> <td align="right" valign="bottom">32.3 (22.5–43.8)</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Race and ethnicity<sup>¶¶</sup></b></b></td> </tr> <tr> <td align="left" valign="bottom">Black or African American</td> <td align="right" valign="bottom">1,381 (1,116–1,704)</td> <td align="right" valign="bottom">4.5 (3.6–5.5)</td> <td align="right" valign="bottom">605 (463–756)</td> <td align="right" valign="bottom">43.8 (33.5–54.7)</td> <td align="right" valign="bottom">NR***</td> <td align="right" valign="bottom">NR***</td> </tr> <tr> <td align="left" valign="bottom">White</td> <td align="right" valign="bottom">5,811 (5,233–6,450)</td> <td align="right" valign="bottom">3.7 (3.3–4.1)</td> <td align="right" valign="bottom">3,503 (3,216–3,779)</td> <td align="right" valign="bottom">60.3 (55.3–65.0)<sup>&dagger;&dagger;</sup></td> <td align="right" valign="bottom">1,725 (1,510–1,940)</td> <td align="right" valign="bottom">49.2 (43.1–55.4)</td> </tr> <tr> <td align="left" valign="bottom">Hispanic or Latino</td> <td align="right" valign="bottom">1,337 (1,051–1,698)</td> <td align="right" valign="bottom">3.0 (2.4–3.8)</td> <td align="right" valign="bottom">611 (464–764)</td> <td align="right" valign="bottom">45.7 (34.7–57.2)</td> <td align="right" valign="bottom">NR***</td> <td align="right" valign="bottom">NR***</td> </tr> <tr> <td align="left" valign="bottom">Other or multiple races</td> <td align="right" valign="bottom">838 (601–1,164)</td> <td align="right" valign="bottom">3.7 (2.6–5.1)</td> <td align="right" valign="bottom">NR***</td> <td align="right" valign="bottom">NR***</td> <td align="right" valign="bottom">NR***</td> <td align="right" valign="bottom">NR***</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Education</b></b></td> </tr> <tr> <td align="left" valign="bottom">Any college</td> <td align="right" valign="bottom">4,764 (4,228–5,366)</td> <td align="right" valign="bottom">2.9 (2.6–3.3)**</td> <td align="right" valign="bottom">2,463 (2,167–2,756)</td> <td align="right" valign="bottom">51.7 (45.5–57.8)</td> <td align="right" valign="bottom">1,061 (887–1,242)</td> <td align="right" valign="bottom">43.1 (36.0–50.4)</td> </tr> <tr> <td align="left" valign="bottom">No college</td> <td align="right" valign="bottom">4,603 (4,064–5,209)</td> <td align="right" valign="bottom">4.9 (4.3–5.6)**</td> <td align="right" valign="bottom">2,704 (2,424–2,973)</td> <td align="right" valign="bottom">58.8 (52.7–64.6)</td> <td align="right" valign="bottom">1,292 (1,088–1,498)</td> <td align="right" valign="bottom">47.8 (40.2–55.4)</td> </tr> <tr> <td align="left" valign="bottom"><b><b>Employment status</b></b></td> <td align="left" valign="bottom"></td> <td align="left" valign="bottom"></td> <td align="left" valign="bottom"></td> <td align="left" valign="bottom"></td> <td align="left" valign="bottom"></td> <td align="left" valign="bottom"></td> </tr> <tr> <td align="left" valign="bottom">Employed full time or part time</td> <td align="right" valign="bottom">3,884 (3,426–4,402)</td> <td align="right" valign="bottom">2.6 (2.3–2.9)**</td> <td align="right" valign="bottom">2,450 (2,191–2,691)</td> <td align="right" valign="bottom">63.1 (56.4–69.3)**</td> <td align="right" valign="bottom">1,287 (1,087–1,483)</td> <td align="right" valign="bottom">52.5 (44.4–60.5)**</td> </tr> <tr> <td align="left" valign="bottom">Unemployed or other employment<b><b><sup>&dagger;&dagger;&dagger;</sup></b></b></td> <td align="right" valign="bottom">5,483 (4,903–6,126)</td> <td align="right" valign="bottom">5.2 (4.7–5.8)**</td> <td align="right" valign="bottom">2,717 (2,405–3,029)</td> <td align="right" valign="bottom">49.6 (43.9–55.3)**</td> <td align="right" valign="bottom">1,066 (886–1,257)</td> <td align="right" valign="bottom">39.2 (32.6–46.3)**</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Ever arrested and booked</b></b></td> </tr> <tr> <td align="left" valign="bottom">Yes</td> <td align="right" valign="bottom">3,620 (3,166–4,130)</td> <td align="right" valign="bottom">9.7 (8.5–11.0)**</td> <td align="right" valign="bottom">2,400 (2,134–2,639)</td> <td align="right" valign="bottom">66.3 (59.0–72.9)**</td> <td align="right" valign="bottom">1,512 (1,316–1,691)</td> <td align="right" valign="bottom">63.0 (54.8–70.5)**</td> </tr> <tr> <td align="left" valign="bottom">No</td> <td align="right" valign="bottom">5,440 (4,856–6,093)</td> <td align="right" valign="bottom">2.5 (2.3–2.8)**</td> <td align="right" valign="bottom">2,570 (2,273–2,871)</td> <td align="right" valign="bottom">47.2 (41.8–52.8)**</td> <td align="right" valign="bottom">781 (628–953)</td> <td align="right" valign="bottom">30.4 (24.4–37.1)**</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Poverty level<sup>§§§</sup></b></b></td> </tr> <tr> <td align="left" valign="bottom"><100% of the federal poverty level</td> <td align="right" valign="bottom">2,708 (2,335–3,134)</td> <td align="right" valign="bottom">7.5 (6.5–8.7)**</td> <td align="right" valign="bottom">1,530 (1,306–1,744)</td> <td align="right" valign="bottom">56.5 (48.3–64.4)</td> <td align="right" valign="bottom">674 (529–826)</td> <td align="right" valign="bottom">44.1 (34.6–54.0)</td> </tr> <tr> <td align="left" valign="bottom">100%–199% of the federal poverty level</td> <td align="right" valign="bottom">2,487 (2,125–2,908)</td> <td align="right" valign="bottom">5.0 (4.3–5.8)**</td> <td align="right" valign="bottom">1,540 (1,349–1,718)</td> <td align="right" valign="bottom">61.9 (54.2–69.1)</td> <td align="right" valign="bottom">714 (570–862)</td> <td align="right" valign="bottom">46.4 (37.0–56.0)</td> </tr> <tr> <td align="left" valign="bottom">≥200% of the federal poverty level</td> <td align="right" valign="bottom">4,172 (3,658–4,756)</td> <td align="right" valign="bottom">2.5 (2.1–2.8)**</td> <td align="right" valign="bottom">2,097 (1,821–2,372)</td> <td align="right" valign="bottom">50.3 (43.6–56.9)</td> <td align="right" valign="bottom">964 (791–1,142)</td> <td align="right" valign="bottom">46.0 (37.7–54.5)</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>U.S. Census Bureau region</b></b><sup>¶¶¶</sup></td> </tr> <tr> <td align="left" valign="bottom">Midwest</td> <td align="right" valign="bottom">2,045 (1,727–2,419)</td> <td align="right" valign="bottom">3.9 (3.3–4.6)</td> <td align="right" valign="bottom">1,084 (892–1,272)</td> <td align="right" valign="bottom">53.0 (43.6–62.2)</td> <td align="right" valign="bottom">478 (370–592)</td> <td align="right" valign="bottom">44.1 (34.2–54.6)</td> </tr> <tr> <td align="left" valign="bottom">Northeast</td> <td align="right" valign="bottom">1,620 (1,310–2,000)</td> <td align="right" valign="bottom">3.6 (2.9–4.4)</td> <td align="right" valign="bottom">1,020 (851–1,172)</td> <td align="right" valign="bottom">63.0 (52.5–72.3)</td> <td align="right" valign="bottom">523 (404–640)</td> <td align="right" valign="bottom">51.2 (39.6–62.7)</td> </tr> <tr> <td align="left" valign="bottom">South</td> <td align="right" valign="bottom">3,745 (3,277–4,278)</td> <td align="right" valign="bottom">3.8 (3.3–4.4)</td> <td align="right" valign="bottom">2,083 (1,836–2,322)</td> <td align="right" valign="bottom">55.6 (49.0–62.0)</td> <td align="right" valign="bottom">1,024 (849–1,201)</td> <td align="right" valign="bottom">49.2 (40.8–57.7)</td> </tr> <tr> <td align="left" valign="bottom">West</td> <td align="right" valign="bottom">1,956 (1,626–2,352)</td> <td align="right" valign="bottom">3.2 (2.7–3.9)</td> <td align="right" valign="bottom">980 (792–1,167)</td> <td align="right" valign="bottom">50.1 (40.5–59.6)</td> <td align="right" valign="bottom">327 (229–442)</td> <td align="right" valign="bottom">33.4 (23.4–45.1)</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Core-based statistical area</b></b>****</td> </tr> <tr> <td align="left" valign="bottom">Metropolitan statistical area</td> <td align="right" valign="bottom">7,789 (7,094–8,550)</td> <td align="right" valign="bottom">3.5 (3.2–3.8)**</td> <td align="right" valign="bottom">4,225 (3,848–4,596)</td> <td align="right" valign="bottom">54.2 (49.4–59.0)</td> <td align="right" valign="bottom">1,975 (1,721–2,233)</td> <td align="right" valign="bottom">46.7 (40.7–52.8)</td> </tr> <tr> <td align="left" valign="bottom">Micropolitan statistical area or outside core-based statistical area</td> <td align="right" valign="bottom">1,578 (1,305–1,904)</td> <td align="right" valign="bottom">4.7 (3.9–5.7)**</td> <td align="right" valign="bottom">942 (789–1,084)</td> <td align="right" valign="bottom">59.7 (50.0–68.7)</td> <td align="right" valign="bottom">377 (278–487)</td> <td align="right" valign="bottom">40.1 (29.5–51.7)</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Overall self-rated health</b></b></td> </tr> <tr> <td align="left" valign="bottom">Excellent or very good</td> <td align="right" valign="bottom">2,333 (1,956–2,781)</td> <td align="right" valign="bottom">1.7 (1.4–2.1)**</td> <td align="right" valign="bottom">1,544 (1,336–1,728)</td> <td align="right" valign="bottom">66.2 (57.3–74.1)<b><b><sup>&dagger;&dagger;&dagger;&dagger;</sup></b></b></td> <td align="right" valign="bottom">790 (623–954)</td> <td align="right" valign="bottom">51.1 (40.3–61.8)</td> </tr> <tr> <td align="left" valign="bottom">Good</td> <td align="right" valign="bottom">3,600 (3,138–4,125)</td> <td align="right" valign="bottom">4.4 (3.8–5.0)**</td> <td align="right" valign="bottom">2,019 (1,769–2,260)</td> <td align="right" valign="bottom">56.1 (49.1–62.8)</td> <td align="right" valign="bottom">899 (741–1,063)</td> <td align="right" valign="bottom">44.5 (36.7–52.7)</td> </tr> <tr> <td align="left" valign="bottom">Fair or poor</td> <td align="right" valign="bottom">3,434 (2,984–3,945)</td> <td align="right" valign="bottom">8.8 (7.7–10.2)**</td> <td align="right" valign="bottom">1,604 (1,349–1,864)</td> <td align="right" valign="bottom">46.7 (39.3–54.3)<b><b><sup>&dagger;&dagger;&dagger;&dagger;</sup></b></b></td> <td align="right" valign="bottom">664 (527–810)</td> <td align="right" valign="bottom">41.4 (32.8–50.5)</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Any mental illness in past year<sup>§§§§</sup></b></b></td> </tr> <tr> <td align="left" valign="bottom">Yes</td> <td align="right" valign="bottom">5,348 (4,844–5,900)</td> <td align="right" valign="bottom">9.0 (8.2–10.0)**</td> <td align="right" valign="bottom">2,957 (2,656–3,251)</td> <td align="right" valign="bottom">55.3 (49.7–60.8)</td> <td align="right" valign="bottom">1,362 (1,154–1,575)</td> <td align="right" valign="bottom">46.1 (39.0–53.3)</td> </tr> <tr> <td align="left" valign="bottom">No</td> <td align="right" valign="bottom">4,019 (3,525–4,580)</td> <td align="right" valign="bottom">2.0 (1.8–2.3)**</td> <td align="right" valign="bottom">2,210 (1,944–2,469)</td> <td align="right" valign="bottom">55.0 (48.4–61.5)</td> <td align="right" valign="bottom">991 (814–1,173)</td> <td align="right" valign="bottom">44.8 (36.8–53.1)</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Used illicit drugs other than opioids in past year<sup>¶¶¶¶</sup></b></b></td> </tr> <tr> <td align="left" valign="bottom">Yes</td> <td align="right" valign="bottom">4,827 (4,275–5,445)</td> <td align="right" valign="bottom">7.6 (6.7–8.6)**</td> <td align="right" valign="bottom">2,955 (2,630–3,261)</td> <td align="right" valign="bottom">61.2 (54.5–67.6)**</td> <td align="right" valign="bottom">1,562 (1,347–1,774)</td> <td align="right" valign="bottom">52.9 (45.6–60.0)**</td> </tr> <tr> <td align="left" valign="bottom">No</td> <td align="right" valign="bottom">4,540 (4,026–5,117)</td> <td align="right" valign="bottom">2.4 (2.1–2.7)**</td> <td align="right" valign="bottom">2,212 (1,949–2,476)</td> <td align="right" valign="bottom">48.7 (42.9–54.6)**</td> <td align="right" valign="bottom">790 (636–960)</td> <td align="right" valign="bottom">35.7 (28.8–43.4)**</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Binge drinking in past month*****</b></b></td> </tr> <tr> <td align="left" valign="bottom">Yes</td> <td align="right" valign="bottom">2,366 (1,986–2,815)</td> <td align="right" valign="bottom">3.9 (3.3–4.7)</td> <td align="right" valign="bottom">1,366 (1,148–1,573)</td> <td align="right" valign="bottom">57.7 (48.5–66.5)</td> <td align="right" valign="bottom">585 (442–737)</td> <td align="right" valign="bottom">42.8 (32.4–53.9)</td> </tr> <tr> <td align="left" valign="bottom">No</td> <td align="right" valign="bottom">7,001 (6,320–7,751)</td> <td align="right" valign="bottom">3.6 (3.2–4.0)</td> <td align="right" valign="bottom">3,801 (3,443–4,152)</td> <td align="right" valign="bottom">54.3 (49.2–59.3)</td> <td align="right" valign="bottom">1,768 (1,539–2,000)</td> <td align="right" valign="bottom">46.5 (40.5–52.6)</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Used marijuana in past year</b></b></td> </tr> <tr> <td align="left" valign="bottom">Yes</td> <td align="right" valign="bottom">4,108 (3,596–4,686)</td> <td align="right" valign="bottom">7.0 (6.1–7.9)**</td> <td align="right" valign="bottom">2,534 (2,223–2,824)</td> <td align="right" valign="bottom">61.7 (54.1–68.7)**</td> <td align="right" valign="bottom">1,344 (1,144–1,541)</td> <td align="right" valign="bottom">53.1 (45.1–60.8)**</td> </tr> <tr> <td align="left" valign="bottom">No</td> <td align="right" valign="bottom">5,259 (4,709–5,871)</td> <td align="right" valign="bottom">2.7 (2.4–3.0)**</td> <td align="right" valign="bottom">2,633 (2,347–2,918)</td> <td align="right" valign="bottom">50.1 (44.6–55.5)**</td> <td align="right" valign="bottom">1,008 (837–1,191)</td> <td align="right" valign="bottom">38.3 (31.8–45.2)**</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Misused central nervous system stimulants in past year<sup>&dagger;&dagger;&dagger;&dagger;&dagger;</sup></b></b></td> </tr> <tr> <td align="left" valign="bottom">Yes</td> <td align="right" valign="bottom">2,057 (1,750–2,402)</td> <td align="right" valign="bottom">20.7 (17.6–24.2)**</td> <td align="right" valign="bottom">1,248 (1,042–1,438)</td> <td align="right" valign="bottom">60.7 (50.6–69.9)</td> <td align="right" valign="bottom">741 (603–869)</td> <td align="right" valign="bottom">59.4 (48.3–69.6)**</td> </tr> <tr> <td align="left" valign="bottom">No</td> <td align="right" valign="bottom">7,310 (6,644–8,041)</td> <td align="right" valign="bottom">3.0 (2.7–3.3)**</td> <td align="right" valign="bottom">3,919 (3,564–4,268)</td> <td align="right" valign="bottom">53.6 (48.8–58.4)</td> <td align="right" valign="bottom">1,611 (1,373–1,861)</td> <td align="right" valign="bottom">41.1 (35.0–47.5)**</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Type of opioid use in past year (among past-year users)<sup>§§§§§</sup></b></b></td> </tr> <tr> <td align="left" valign="bottom">Misused</td> <td align="right" valign="bottom">3,059 (2,735–3,400)</td> <td align="right" valign="bottom">35.9 (32.1–39.9)**</td> <td align="right" valign="bottom">1,562 (1,353–1,771)</td> <td align="right" valign="bottom">51.1 (44.2–57.9)</td> <td align="right" valign="bottom">964 (838–1,080)</td> <td align="right" valign="bottom">61.7 (53.6–69.1)**</td> </tr> <tr> <td align="left" valign="bottom">Used but did not misuse</td> <td align="right" valign="bottom">5,850 (5,671–7,014)</td> <td align="right" valign="bottom">9.4 (8.4–10.4)**</td> <td align="right" valign="bottom">3,169 (2,831–3,500)</td> <td align="right" valign="bottom">54.2 (48.4–59.8)</td> <td align="right" valign="bottom">1,135 (937–1,348)</td> <td align="right" valign="bottom">35.8 (29.6–42.5)**</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>Substance use disorder other than OUD in past year</b></b><sup>¶¶¶¶¶</sup></td> </tr> <tr> <td align="left" valign="bottom">Yes</td> <td align="right" valign="bottom">4,551 (4,047–5,110)</td> <td align="right" valign="bottom">10.4 (9.3–11.7)**</td> <td align="right" valign="bottom">2,565 (2,280–2,841)</td> <td align="right" valign="bottom">56.4 (50.1–62.4)</td> <td align="right" valign="bottom">1,328 (1,126–1,528)</td> <td align="right" valign="bottom">51.8 (43.9–59.6)**</td> </tr> <tr> <td align="left" valign="bottom">No</td> <td align="right" valign="bottom">4,816 (4,298–5,394)</td> <td align="right" valign="bottom">2.3 (2.0–2.5)**</td> <td align="right" valign="bottom">2,602 (2,331–2,868)</td> <td align="right" valign="bottom">54.0 (48.4–59.5)</td> <td align="right" valign="bottom">1,025 (851–1,209)</td> <td align="right" valign="bottom">39.4 (32.7–46.5)**</td> </tr> <tr> <td colspan="7" align="left" valign="bottom"><b><b>OUD severity******</b></b></td> </tr> <tr> <td align="left" valign="bottom">Severe</td> <td align="right" valign="bottom">1,384 (1,115–1,717)</td> <td align="right" valign="bottom">100<b><b><sup>&dagger;&dagger;&dagger;&dagger;&dagger;&dagger;</sup></b></b></td> <td align="right" valign="bottom">734 (587–878)</td> <td align="right" valign="bottom">53.0 (42.4–63.4)**</td> <td align="right" valign="bottom">593 (522–644)</td> <td align="right" valign="bottom">80.7 (71.1–87.7)**</td> </tr> <tr> <td align="left" valign="bottom">Mild or moderate</td> <td align="right" valign="bottom">4,467 (3,925–5,084)</td> <td align="right" valign="bottom">100<b><b><sup>&dagger;&dagger;&dagger;&dagger;&dagger;&dagger;</sup></b></b></td> <td align="right" valign="bottom">917 (729–1,140)</td> <td align="right" valign="bottom">20.5 (16.3–25.5)**</td> <td align="right" valign="bottom">509 (405–608)</td> <td align="right" valign="bottom">55.5 (44.1–66.3)**</td> </tr> <tr> <td align="left" valign="bottom">Did not meet criteria for an active OUD in past year</td> <td align="right" valign="bottom">3,515 (3,082–4,009)</td> <td align="right" valign="bottom">1.4 (1.2–1.6)</td> <td align="right" valign="bottom">3,515 (3,141–3,906)</td> <td align="right" valign="bottom">100**<sup>,</sup><b><b><sup>§§§§§§</sup></b></b></td> <td align="right" valign="bottom">1,251 (1,029–1,492)</td> <td align="right" valign="bottom">35.6 (29.3–42.4)**</td> </tr> </tbody> </table> <p class="caption"><b><b>Abbreviations:</b></b> DSM-IV = <i><i>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition</i></i>; DSM-5 = <i><i>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition</i></i>; NR = not reported; OUD = opioid use disorder.<br> * In thousands; estimates are weighted.<br> <sup>&dagger;</sup> Adults who needed OUD treatment were defined as those who met DSM-5 criteria for OUD or received OUD treatment in the past year.<br> <sup>§</sup> Among adults who needed OUD treatment. Adults were classified as having received OUD treatment in the past year if they met any of the following criteria: 1) received inpatient treatment for opioid use, outpatient treatment for opioid use, or medications for OUD in the past year, 2) received inpatient or outpatient treatment in the past year for a substance that they did not specify in the survey, and had past-year opioid use, or 3) did NOT receive inpatient or outpatient substance use treatment, but received substance use treatment virtually or in a prison or jail for an unspecified substance, and had past-year opioid use.<br> <sup>¶</sup> Among those who needed and received any OUD treatment. Medication for OUD was defined as having been prescribed medication in the past 12 months to cut back or stop the use of opioids.<br> ** Statistical tests indicate differences between all groups at the 0.05 significance level.<br> <sup>&dagger;&dagger;</sup> Statistical tests indicate differences for this group relative to other groups at the 0.05 significance level.<br> <sup>§§</sup> Statistical tests indicate differences between those aged 18–25 and 26–34 years at the 0.05 significance level.<br> <sup>¶¶</sup> Persons of Hispanic or Latino (Hispanic) origin might be of any race but are categorized as Hispanic; all racial groups are non-Hispanic.<br> *** Estimate was not reported because of low precision.<br> <sup>&dagger;&dagger;&dagger;</sup> Other employment includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.<br> <sup>§§§</sup> Poverty level indicates a person’s family income relative to poverty thresholds. The U.S. Census Bureau assigns a poverty threshold for each combination of family size and number of children in the household. The measure excludes persons aged 18–22 years living in a college dorm.<br> <sup>¶¶¶</sup> <a href="https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf" target="_blank" class="tp-link-policy" data-domain-ext="gov">https://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdf<span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf x16 fill-pdf" alt="" aria-hidden="true"></span><span class="file-details"></span><span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a><br> **** The core-based statistical areas are classifications for all U.S. counties based on the March 2020 core-based statistical area classification provided by the Office of Management and Budget.<br> <sup>&dagger;&dagger;&dagger;&dagger; </sup>Statistical tests indicate differences between excellent or very good and fair or poor at the 0.05 significance level.<br> <sup>§§§§</sup> Any mental illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status.<br> <sup>¶¶¶¶</sup> Illicit drug use other than opioid use includes the use of cocaine, hallucinogens, inhalants, marijuana, or methamphetamine, or misuse of prescription tranquilizers, sedatives, or stimulants.<br> ***** Defined for females as drinking four or more drinks on the same occasion and for males as drinking five or more drinks on the same occasion on ≥1 day in the past 30 days.<br> <sup>&dagger;&dagger;&dagger;&dagger;&dagger;</sup> Central nervous system stimulant misuse includes use the use of cocaine or methamphetamine or misuse of prescription stimulants.<br> <sup>§§§§§ </sup>Misuse includes use of heroin or use of prescription pain relievers in any way not directed by a health care professional. “Use but not misuse” was defined as using only prescription pain relievers as directed by a health care professional.<br> <sup>¶¶¶¶¶</sup> Includes use disorders for alcohol, cocaine, hallucinogens, inhalants, marijuana, methamphetamine, prescription sedatives, prescription stimulants, or prescription tranquilizers.<br> ****** OUD severity level is determined by the number of individual DSM-5 criteria met for OUD. Mild or moderate OUD means two to five criteria were met. Severe OUD means six or more criteria were met. Persons who did not meet criteria for an active OUD in the past year and received OUD treatment in the past year were assumed to have had an active OUD in the past and to have successfully treated OUD with continued treatment.<br> <sup>&dagger;&dagger;&dagger;&dagger;&dagger;&dagger;</sup> By definition, 100% of adults with OUD or who received OUD treatment were classified as needing OUD treatment.<br> <sup>§§§§§§</sup> By definition, among adults who 1) did not meet the criteria for an active OUD based on past-year symptoms and 2) were classified as needing OUD treatment in the past year; 100% received OUD treatment.</p> </div><div class="order-4"><p class="text-right"><a href="#">Top</a></p></div><br><div class="theme-indigo card bg-tertiary w-100 order-4"><div class="card-body"><p id="suggestedcitation" class="smallgrey"><strong>Suggested citation for this article:</strong> Dowell D, Brown S, Gyawali S, et al. Treatment for Opioid Use Disorder: Population Estimates — United States, 2022. MMWR Morb Mortal Wkly Rep 2024;73:567–574. DOI: <a href="http://dx.doi.org/10.15585/mmwr.mm7325a1" target="_blank" rel="noopener noreferrer" class="tp-link-policy" data-domain-ext="org">http://dx.doi.org/10.15585/mmwr.mm7325a1<span aria-label="external icon" class="sr-only" role="img"></span><span class="fi cdc-icon-external x16 fill-external" alt="" aria-hidden="true"></span></a>.</p> </div></div><div class="pull-left order-4 w-100"><p><small> <i>MMWR</i> and <i>Morbidity and Mortality Weekly Report</i> are service marks of the U.S. Department of Health and Human Services.<br /> Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. <br />References to non-CDC sites on the Internet are provided as a service to <i>MMWR</i> readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in <i>MMWR</i> were current as of the date of publication.</small></p> <p><small>All HTML versions of <i>MMWR</i> articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (<a href="https://www.cdc.gov/mmwr">https://www.cdc.gov/mmwr</a>) and/or the original <i>MMWR</i> paper copy for printable versions of official text, figures, and tables. </small></p> <p><small>Questions or messages regarding errors in formatting should be addressed to <a href="https://www.cdc.gov/mmwr/form/index.html">mmwrq@cdc.gov</a>.</small></div></div> </div> </div> </div> <div class="row"><div class="col page-format">View Page In:<a href="/mmwr/volumes/73/wr/pdfs/mm7325a1-H.pdf" target="_blank" rel="noopener noreferrer"><span class="icon x24"><span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf fill-pdf" alt="" aria-hidden="true"></span></span> Article PDF</a><a href="/mmwr/volumes/73/wr/pdfs/mm7325-H.pdf" target="_blank" rel="noopener noreferrer"><span class="icon x24"><span aria-label="pdf icon" class="sr-only" role="img"></span><span class="fi cdc-icon-pdf fill-pdf" alt="" aria-hidden="true"></span></span> Full Issue PDF</a><a href="https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.11977"><span class="icon x24"></span> Major gaps in the cascade of care for opioid use disorder: implications for clinical practice</a></div></div> <div class="row d-none d-lg-block"> <div class="col pca"> </div> </div> <div class="row share-row last-reviewed-row"> <div class="col-md last-reviewed"> Last Reviewed: <span id="last-reviewed-date">June 27, 2024</span> <div class="d-none d-lg-block content-source">Source: <a href="//www.cdc.gov/" class="td-none">Centers for Disease Control and Prevention</a> </div> </div> <div class="col-md page-share ml-auto"> <nav id="share-nav" class="page-share-wrapper" role="navigation" aria-label="Social Media"> <ul> <li><a target="_blank" title="Share to Facebook" rel="noreferrer noopener" class="page-share-facebook metrics-share-facebook" href="https://api.addthis.com/oexchange/0.8/forward/facebook/offer?url=https%3A%2F%2Fwww.cdc.gov%2Findex.htm&title=CDC%20Works%2024/7&description=As%20the%20nation%27s%20health%20protection%20agency,%20CDC%20saves%20lives%20and%20protects%20people%20from%20health,%20safety,%20and%20security%20threats.&via=CDCgov&ct=0&media=https://www.cdc.gov/homepage/images/centers-for-disease-control-and-prevention.png"><span class="sr-only">Facebook</span><span class="fi cdc-icon-fb-round"></span></a></li> <li><a target="_blank" title="Share to Twitter" rel="noreferrer noopener" class="page-share-twitter metrics-share-twitter" href="https://api.addthis.com/oexchange/0.8/forward/twitter/offer?url=https%3A%2F%2Fwww.cdc.gov%2Findex.htm&title=CDC%20Works%2024/7&description=As%20the%20nation%27s%20health%20protection%20agency,%20CDC%20saves%20lives%20and%20protects%20people%20from%20health,%20safety,%20and%20security%20threats.&via=CDCgov&ct=0&media=https://www.cdc.gov/homepage/images/centers-for-disease-control-and-prevention.png"><span class="sr-only">Twitter</span><span class="fi cdc-icon-twitter-round"></span></a></li> <li><a target="_blank" title="Share to LinkedIn" rel="noreferrer noopener" class="page-share-linkedin metrics-share-linkedin" href="https://api.addthis.com/oexchange/0.8/forward/linkedin/offer?url=https%3A%2F%2Fwww.cdc.gov%2Findex.htm&title=CDC%20Works%2024/7&description=As%20the%20nation%27s%20health%20protection%20agency,%20CDC%20saves%20lives%20and%20protects%20people%20from%20health,%20safety,%20and%20security%20threats.&via=CDCgov&ct=0&media=https://www.cdc.gov/homepage/images/centers-for-disease-control-and-prevention.png"><span class="sr-only">LinkedIn</span><span class="fi cdc-icon-linkedin-round"></span></a></li> <li><a target="_blank" title="Embed this Page" rel="noreferrer noopener" class="page-share-syndication metrics-share-syndicate" href="https://tools.cdc.gov/medialibrary/index.aspx#/sharecontent/https%3A%2F%2Fwww.cdc.gov%2Findex.htm"><span class="sr-only">Syndicate</span><span class="fi cdc-icon-syndication-round"></span></a></li> </ul> </nav> </div> </div> </main> <div class="col-12 d-lg-none leftnav-wrapper"> <nav role="navigation" aria-label="Left Navigation Menu"> <div id="cdc-left-nav-menu" data-menu-id="455"><ul class="list-group tp-nav-main"><li class="list-group-item nav-lvl1"><a href="/mmwr/index.html">MMWR</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/mmwr_additional_resources.html">Reports by Topic</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/publications/index.html">Publications</a><a href="#nav-group-9300a" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-9300a"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-9300a" class="collapse"><li class="list-group-item nav-lvl2"><a href="/mmwr/index2025.html">Weekly Report</a><a href="#nav-group-61c66" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-61c66"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-61c66" class="collapse"><li class="list-group-item nav-lvl3"><a href="/mmwr/mmwr_wk/wk_pvol.html">Past Volumes (1982-2024)</a></li></ul></li><li class="list-group-item nav-lvl2"><a href="/mmwr/indrr_2024.html">Recommendations and Reports</a><a href="#nav-group-60bf3" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-60bf3"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-60bf3" class="collapse"><li class="list-group-item nav-lvl3"><a href="/mmwr/mmwr_rr/rr_pvol.html">Past Volumes (1990-2022)</a></li></ul></li><li class="list-group-item nav-lvl2"><a href="/mmwr/indss_2024.html">Surveillance Summaries</a><a href="#nav-group-7d9b1" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-7d9b1"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-7d9b1" class="collapse"><li class="list-group-item nav-lvl3"><a href="/mmwr/mmwr_ss/ss_pvol.html">Past Volumes (1983-2023)</a></li></ul></li><li class="list-group-item nav-lvl2"><a href="/mmwr/ind2024_su.html">Supplements</a><a href="#nav-group-7189d" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-7189d"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-7189d" class="collapse"><li class="list-group-item nav-lvl3"><a href="/mmwr/mmwr_su/index.html">Past Volumes (1985-2023)</a></li></ul></li><li class="list-group-item nav-lvl2"><a href="https://stacks.cdc.gov/cbrowse/?parentId=cdc:101&pid=cdc:101">Archive (1952-1981)</a></li><li class="list-group-item nav-lvl2"><a href="/mmwr/mmwr_nd/index.html">Notifiable Infectious Diseases</a></li><li class="list-group-item nav-lvl2"><a href="/mmwr/mmwr_nnc/index.html">Notifiable Noninfectious Conditions</a></li></ul></li><li class="list-group-item nav-lvl1"><a href="https://www.cdc.gov/vitalsigns/index.html">Vital Signs</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/va-search/visualAbstract.htm?Sort=Date%3A%3Adesc">Visual Abstracts</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/mmwrpodcasts.html">Podcasts</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/cme/medscape_cme.html">Continuing Education</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/newsletter/cmo/index2024.html">MMWR Clinical Pearls</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/mmwr_trends-widget.html">Metrics</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/contributors/index.html">For Authors</a></li><li class="list-group-item nav-lvl1"><a href="/mmwr/about.html">About  </a><a href="#nav-group-a977d" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-a977d"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-a977d" class="collapse"><li class="list-group-item nav-lvl2"><a href="/mmwr/staff/staff.html">Staff</a></li><li class="list-group-item nav-lvl2"><a href="/mmwr/editorial_board.html">Editorial Board</a></li></ul></li><li class="list-group-item nav-lvl1"><a href="/mmwr/mmwrsubscribe.html">Subscribe</a><a href="#nav-group-2406c" class="nav-plus nav-expandcollapse" data-toggle="collapse" aria-controls="nav-group-2406c"><span class="sr-only">plus icon</span><span class="fi cdc-icon-plus" aria-hidden="true"></span></a><ul id="nav-group-2406c" class="collapse"><li class="list-group-item nav-lvl2"><a href="https://tools.cdc.gov/api/v2/resources/media/342778.rss">RSS Feed</a></li></ul></li></ul></div> </nav> <div class="col-12 mt-5"> </div> </div> </div> <footer class="" role="contentinfo" aria-label="Footer"> <div class="container-fluid footer-wrapper"> <div class="container"> <div class="footer-2022"> <div class="footer-desktop"> <div class="row"> <div class="col-6 about"> <ul class="d-flex"> <li><a href="https://www.cdc.gov/about/">About CDC</a></li> <li><a href="https://www.cdc.gov/cdc-info/index.html">Contact Us</a></li> <li><a href="tel:8002324636">800-232-4636</a></li> </ul> </div> <div class="col-6 social"> <div class="d-flex flex-nowrap"> <a href="https://www.facebook.com/CDC" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-facebook-inverse"></span><span class="sr-only">Facebook</span></a> <a href="https://twitter.com/CDCgov" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-twitter-inverse"></span><span class="sr-only">Twitter</span></a> <a href="https://www.instagram.com/CDCgov/" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-instagram-inverse"></span><span class="sr-only">Instagram</span></a> <a href="https://www.linkedin.com/company/centers-for-disease-control-and-prevention" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-linkedin-inverse"></span><span class="sr-only">LinkedIn</span></a> <a href="https://www.youtube.com/c/cdc/" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-youtube-inverse"></span><span class="sr-only">Youtube</span></a> <a href="https://www.pinterest.com/cdcgov/" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-pinterest-inverse"></span><span class="sr-only">Pinterest</span></a> <a href="https://www.snapchat.com/add/cdcgov" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-snapchat-inverse"></span><span class="sr-only">Snapchat</span></a> <a href="https://tools.cdc.gov/medialibrary/index.aspx" target="_blank" rel="noreferrer noopener"><span class="cdc-icon-rss-inverse" aria-hidden="true"></span><span class="sr-only">RSS</span></a> </div> </div> </div> </div> <div class="footer-mobile" aria-label="Footer" role="contentinfo"> <ul class="accordion indicator-arrow mb-3" role="tablist" aria-busy="true"> <li class="card footer-mobile_contact" role="presentation"> <button role="tab" class="card-header tab collapsed" data-target="#footer-mobile-collapse-1" data-toggle="collapse" aria-expanded="false" id="footer-mobile-card-1" >CONTACT CDC</button> <div class="collapse" id="footer-mobile-collapse-1" role="tabpanel" aria-hidden="true"> <div class="card-body"> <address itemscope="itemscope" itemtype="https://schema.org/Organization"> <div class="row mt-2"> <div class="col-1"> <span aria-hidden="true" class="fi cdc-icon-desktop x24"></span> </div> <div class="col"> <span class="pl-1"><a href="https://www.cdc.gov/cdc-info/index.html">Contact Us</a></span> </div> </div> <div class="row mt-2"> <div class="col-1"> <span class="fi cdc-icon-phone x24"></span> </div> <div class="col"> <span class="pl-1" itemprop="telephone">Call 800-232-4636</span> </div> </div> <div class="row mt-2"> <div class="col-1"> <span class="fi cdc-icon-email x24"></span> </div> <div class="col"> <span class="pl-1" itemprop="url"><a href="https://www.cdc.gov/cdc-info/index.html">Email Us</a></span> </div> </div> </address> </div> </div> </li> <li class="card footer-mobile_about" role="presentation"> <button role="tab" class="card-header tab collapsed " data-target="#footer-mobile-collapse-2" data-toggle="collapse" aria-expanded="false" id="footer-mobile-card-2" >ABOUT CDC</button> <div class="collapse" id="footer-mobile-collapse-2" role="tabpanel" aria-hidden="true"> <div class="card-body"> <ul> <li><a href="https://www.cdc.gov/about/default.htm">About CDC</a></li> <li><a href="https://jobs.cdc.gov">Jobs</a></li> <li><a href="https://www.cdc.gov/funding">Funding</a></li> </ul> </div> </div> </li> <li class="card footer-mobile_policies" role="presentation"> <button role="tab" class="card-header tab collapsed " data-target="#footer-mobile-collapse-3" data-toggle="collapse" aria-expanded="false" id="footer-mobile-card-3">POLICIES</button> <div class="collapse" id="footer-mobile-collapse-3" role="tabpanel" aria-hidden="true"> <div class="card-body"> <ul> <li><a href="https://www.cdc.gov/other/accessibility.html">Accessibility</a></li> <li><a href="https://www.cdc.gov/Other/disclaimer.html">External Links</a></li> <li><a href="https://www.cdc.gov/other/privacy.html">Privacy</a></li> <li><a href="https://www.cdc.gov/Other/policies.html">Web Policies</a></li> <li><a href="https://www.cdc.gov/od/foia">FOIA</a></li> <li><a href="https://oig.hhs.gov">OIG</a></li> <li><a href="https://www.cdc.gov/oeeowe/no-fear-act/">No Fear Act</a></li> <li><a href="https://www.cdc.gov/other/nondiscrimination.html">Nondiscrimination</a></li> <li><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html">Vulnerability Disclosure Policy</a></li> <li><a href="https://archive.cdc.gov/">CDC Archive</a></li> <li><a href="https://stacks.cdc.gov/ ">Public Health Publications</a></li> <li><a href="https://hhs.gov/">HHS.gov</a></li> <li><a href="https://www.usa.gov/">USA.gov</a></li> </ul> </div> </div> </li> <li class="card footer-mobile_connect" role="presentation"> <button role="tab" class="card-header tab collapsed " data-target="#footer-mobile-collapse-4" data-toggle="collapse" aria-expanded="false" id="footer-mobile-card-4">CONNECT WITH US</button> <div class="collapse" id="footer-mobile-collapse-4" role="tabpanel" aria-hidden="true"> <div class="card-body"> <ul class="bullet-list cc-4 lsp-out row"> <div class="col-12"> <li><a href="https://www.facebook.com/CDC" target="_blank" rel="noreferrer noopener"><span class="sr-only">Facebook</span><span class="fi cdc-icon-fb-white x24" aria-hidden="true"></span></a></li> <li><a href="https://twitter.com/CDCgov" target="_blank" rel="noreferrer noopener"><span class="sr-only">Twitter</span><span class="fi cdc-icon-twitter-white x24" aria-hidden="true"></span></a></li> <li><a href="https://www.instagram.com/CDCgov/" target="_blank" rel="noreferrer noopener"><span class="sr-only">Instagram</span><span class="fi cdc-icon-ig-white x24" aria-hidden="true"></span></a></li> <li><a href="https://www.linkedin.com/company/centers-for-disease-control-and-prevention" target="_blank" rel="noreferrer noopener"><span class="sr-only">LinkedIn</span><span class="fi cdc-icon-linkedin-white x24" aria-hidden="true"></span></a></li> </div> <div class="col-12"> <li><a href="https://www.youtube.com/c/cdc/" target="_blank" rel="noreferrer noopener"><span class="sr-only">Youtube</span><span class="fi cdc-icon-youtube-white x24" aria-hidden="true"></span></a></li> <li><a href="https://www.pinterest.com/cdcgov/" target="_blank" rel="noreferrer noopener"><span class="sr-only">Pinterest</span><span class="fi cdc-icon-pinterest-white x24" aria-hidden="true"></span></a></li> <li><a href="https://www.snapchat.com/add/cdcgov" target="_blank" rel="noreferrer noopener"><span class="sr-only">Snapchat</span><span class="fi cdc-icon-snapchat x24" aria-hidden="true"></span></a></li> <li><a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx"><span class="sr-only">Email</span><span class="fi cdc-icon-email x24" aria-hidden="true"></span></a></li> </div> </ul> </div> </div> </li> <li class="card footer-mobile_language" role="presentation"> <button role="tab" class="card-header tab collapsed " data-target="#footer-mobile-collapse-5" data-toggle="collapse" aria-expanded="false" id="footer-mobile-card-5">LANGUAGES</button> <div class="collapse" id="footer-mobile-collapse-5" role="tabpanel" aria-hidden="true"> <div class="card-body"> <ul class="bullet-list cc-2 lsp-out"> <li lang="es"><a href="https://www.cdc.gov/other/language-assistance.html#Spanish" title="Spanish">Español</a></li> <li lang="zh"><a href="https://www.cdc.gov/other/language-assistance.html#Chinese" title="Chinese">繁體中文</a></li> <li lang="vi"><a href="https://www.cdc.gov/other/language-assistance.html#Vietnamese" title="Vietnamese">Tiếng Việt</a></li> <li lang="ko"><a href="https://www.cdc.gov/other/language-assistance.html#Korean" title="Korean">한국어</a></li> <li lang="tl"><a href="https://www.cdc.gov/other/language-assistance.html#Tagalog" title="Tagalog">Tagalog</a></li> <li lang="ru"><a href="https://www.cdc.gov/other/language-assistance.html#Russian" title="Russian">Русский</a></li> <li lang="ar"><a href="https://www.cdc.gov/other/language-assistance.html#Arabic" title="Arabic">العربية</a></li> <li lang="ht"><a href="https://www.cdc.gov/other/language-assistance.html#Haitian" title="Haitian">Kreyòl Ayisyen</a></li> <li lang="fr"><a href="https://www.cdc.gov/other/language-assistance.html#French" title="French">Français</a></li> <li lang="pl"><a href="https://www.cdc.gov/other/language-assistance.html#Polish" title="Polish">Polski</a></li> <li lang="pt"><a href="https://www.cdc.gov/other/language-assistance.html#Portuguese" title="Portuguese">Português</a></li> <li lang="it"><a href="https://www.cdc.gov/other/language-assistance.html#Italian" title="Italian">Italiano</a></li> <li lang="de"><a href="https://www.cdc.gov/other/language-assistance.html#German" title="German">Deutsch</a></li> <li lang="ja"><a href="https://www.cdc.gov/other/language-assistance.html#Japanese" title="Japanese">日本語</a></li> <li lang="fa"><a href="https://www.cdc.gov/other/language-assistance.html#Farsi" title="Farsi">فارسی</a></li> <li lang="en"><a href="https://www.cdc.gov/other/language-assistance.html#English" title="English">English</a></li> </ul> </div> </div> </li> </ul> </div> </div> </div> </div> <div class="container-fluid agency-footer"> <div class="container"> <div class="footer-2022 footer-agency row"> <div class="col"> <ul> <li class="d-none d-md-block"><a href="https://www.cdc.gov/other/accessibility.html">Accessibility</a></li> <li class="d-none d-md-block"><a href="https://www.cdc.gov/Other/disclaimer.html">External Links</a></li> <li class="d-none d-md-block"><a href="https://www.cdc.gov/other/privacy.html">Privacy</a></li> <li class="d-none d-md-block"><a href="https://www.cdc.gov/Other/policies.html">Web Policies</a></li> <li class="d-none d-md-block"><a href="https://www.cdc.gov/od/foia">FOIA</a></li> <li class="d-none d-md-block"><a href="https://oig.hhs.gov">OIG</a></li> <li class="d-none d-md-block"><a href="https://www.cdc.gov/oeeowe/no-fear-act/">No Fear Act</a></li> <li class="d-none d-md-block"><a href="https://www.cdc.gov/other/nondiscrimination.html">Nondiscrimination</a></li> <li class="d-none d-md-block"><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html">Vulnerability Disclosure Policy</a></li> <li class="d-none d-md-block"><a href="https://archive.cdc.gov/">CDC Archive</a></li> <li class="d-none d-md-block"><a href="https://stacks.cdc.gov/ ">Public Health Publications</a></li> <li><a href="https://hhs.gov/">HHS.gov</a></li> <li><a href="https://www.usa.gov/">USA.gov</a></li> </ul> </div> </div> </div> </div> </footer>  <script src="/config/cdc_config.js"></script> <script>var CDC_POST={"id":"826_112997","type":"cdc_mmwr","tax":{"cdc_topics":["988a2028-035e-4dd6-9496-699d07f19ed5","71afb58c-f778-4576-a4d2-e85d9c0703f2","f7b194c6-0bf0-454d-945e-3764a99bc4ed"],"cdc_categories":["2b55e648-eaa5-4e53-9b50-833393d2da21"],"cdc_audiences":["8b6abe0c-17bc-4bf4-ac79-9c45a9a6f2af","39e8fbbb-c0e3-4c3e-993e-6bb1af48ef94"],"cdc_populations":["997bc64d-d2ab-404a-90c5-f345e2e11c60"],"cdc_geolocation":["c06140e6-afa9-42d6-94f0-9c234976a4dd"]}};</script> <script src="/TemplatePackage/contrib/libs/jquery/latest/jquery.min.js?_=82471"></script> <script src="/TemplatePackage/contrib/libs/bootstrap/latest/js/bootstrap.bundle.min.js?_=82471"></script>    <script src="/TemplatePackage/contrib/libs/cdc/ab/4.0.0/ab.js"></script> <script src="/TemplatePackage/4.0/assets/js/app.min.js?_=82471"></script> <svg viewBox="0 0 40 40" class="d-none"> <radialGradient id="svg_ig_1" cx="-3.0686" cy="30.0001" r="39.8188" gradientTransform="matrix(0.9138 -0.3831 0.3831 0.9138 -6.346 8.975)" gradientUnits="userSpaceOnUse"> <stop offset="0" style="stop-color:#FFDD55"/> <stop offset="0.1" style="stop-color:#FFDD55"/> <stop offset="0.5" style="stop-color:#FF543E"/> <stop offset="1" style="stop-color:#C837AB"/> </radialGradient> <circle style="fill:url(#svg_ig_1);" cx="20" cy="20" r="20"/> <radialGradient id="svg_ig_2" cx="9.873329e-02" cy="-0.6373" r="22.6462" gradientTransform="matrix(0.9909 0 0 0.9909 -0.2262 -0.2261)" gradientUnits="userSpaceOnUse"> <stop offset="0" style="stop-color:#3771C8"/> <stop offset="0.128" style="stop-color:#3771C8"/> <stop offset="1" style="stop-color:#6600FF;stop-opacity:0"/> </radialGradient> <circle style="fill:url(#svg_ig_2);" cx="20" cy="20" r="20"/> <path class="fill-w" d="M20,5.5c-4,0-4.5,0-6.1,0.1c-1.6,0.1-2.6,0.3-3.6,0.7C9.4,6.7,8.5,7.2,7.7,8C6.9,8.8,6.4,9.7,6,10.6c-0.4,0.9-0.6,2-0.7,3.6c-0.1,1.6-0.1,2.1-0.1,6.1s0,4.5,0.1,6.1C5.4,28,5.6,29,6,30c0.4,1,0.9,1.8,1.7,2.6c0.8,0.8,1.6,1.3,2.6,1.7c0.9,0.4,2,0.6,3.6,0.7c1.6,0.1,2.1,0.1,6.1,0.1c4,0,4.5,0,6.1-0.1c1.6-0.1,2.6-0.3,3.6-0.7c1-0.4,1.8-0.9,2.6-1.7c0.8-0.8,1.3-1.6,1.7-2.6c0.4-0.9,0.6-2,0.7-3.6c0.1-1.6,0.1-2.1,0.1-6.1s0-4.5-0.1-6.1c-0.1-1.6-0.3-2.6-0.7-3.6c-0.4-1-0.9-1.8-1.7-2.6c-0.8-0.8-1.6-1.3-2.6-1.7c-0.9-0.4-2-0.6-3.6-0.7C24.5,5.6,24,5.5,20,5.5L20,5.5z M18.7,8.2c0.4,0,0.8,0,1.3,0c3.9,0,4.4,0,6,0.1c1.4,0.1,2.2,0.3,2.7,0.5c0.7,0.3,1.2,0.6,1.7,1.1c0.5,0.5,0.8,1,1.1,1.7c0.2,0.5,0.4,1.3,0.5,2.7c0.1,1.6,0.1,2,0.1,6s0,4.4-0.1,6c-0.1,1.4-0.3,2.2-0.5,2.7c-0.3,0.7-0.6,1.2-1.1,1.7c-0.5,0.5-1,0.8-1.7,1.1c-0.5,0.2-1.3,0.4-2.7,0.5c-1.6,0.1-2,0.1-6,0.1c-3.9,0-4.4,0-6-0.1c-1.4-0.1-2.2-0.3-2.7-0.5c-0.7-0.3-1.2-0.6-1.7-1.1c-0.5-0.5-0.8-1-1.1-1.7C8.3,28.5,8,27.7,8,26.3c-0.1-1.6-0.1-2-0.1-6s0-4.4,0.1-6c0.1-1.4,0.3-2.2,0.5-2.7c0.3-0.7,0.6-1.2,1.1-1.7c0.5-0.5,1-0.8,1.7-1.1c0.5-0.2,1.3-0.4,2.7-0.5C15.4,8.2,15.9,8.2,18.7,8.2L18.7,8.2z M27.9,10.7c-1,0-1.8,0.8-1.8,1.8c0,1,0.8,1.8,1.8,1.8s1.8-0.8,1.8-1.8S28.9,10.7,27.9,10.7L27.9,10.7z M20,12.7c-4.2,0-7.6,3.4-7.6,7.6s3.4,7.6,7.6,7.6c4.2,0,7.6-3.4,7.6-7.6S24.2,12.7,20,12.7L20,12.7z M20,15.4c2.7,0,4.9,2.2,4.9,4.9c0,2.7-2.2,4.9-4.9,4.9c-2.7,0-4.9-2.2-4.9-4.9C15.1,17.6,17.3,15.4,20,15.4z"/> </svg> <svg id="multicolor_icons" style="display:none" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">  <symbol id="powerpoint" viewBox="0 0 40 40"> <path class="fill-ppt-1" d="M21,1.5h2.45V5.39c4.61,0,9.23,0,13.84,0A1.5,1.5,0,0,1,39,7.08c.07,8.06,0,16.13,0,24.2a5.07,5.07,0,0,1-.41,2.61,3.88,3.88,0,0,1-2.19.43c-4.32,0-8.63,0-13,0v4.32H20.76C14.18,37.43,7.59,36.33,1,35.17Q1,20.07,1,5C7.66,3.81,14.32,2.64,21,1.5Z"></path> <path class="fill-ppt-2" d="M23.44,6.68H37.69V33H23.44V29.56H33.8V27.83H23.44V25.68H33.8V23.95H23.45c0-.85,0-1.69,0-2.54a6.06,6.06,0,0,0,5.18-.51,5.91,5.91,0,0,0,2.66-4.71c-1.9,0-3.79,0-5.68,0,0-1.88,0-3.76,0-5.63L23.44,11Z"></path> <path class="fill-ppt-1" d="M26.47,9.65a6.07,6.07,0,0,1,5.68,5.66c-1.9,0-3.79,0-5.69,0C26.46,13.42,26.46,11.53,26.47,9.65Z"></path> <path class="fill-ppt-2" d="M7.93,12.91c2.34.11,5.18-.93,7.13.83,1.86,2.26,1.37,6.41-1.39,7.76a6.37,6.37,0,0,1-3.17.4q0,2.53,0,5.06l-2.57-.22C7.88,22.13,7.87,17.52,7.93,12.91Z"></path> <path class="fill-ppt-1" d="M10.49,15.24c.85,0,1.9-.19,2.48.6A3.13,3.13,0,0,1,13,18.68c-.49.89-1.61.8-2.47.91C10.47,18.14,10.48,16.69,10.49,15.24Z"></path> </symbol> <symbol id="pdf" viewBox="0 0 40 40"> <path class="fill-pdf-1" d="M32.52,1H1.45V38.68h38V7.42Z"></path> <polygon class="fill-op-2" points="39.38 7.49 32.96 7.49 32.52 1.06 39.38 7.49"></polygon> <path class="fill-pdf-2" d="M16.28,23C17,21.57,17.84,20,18.5,18.33h0l.26-.64c-.86-3.3-1.38-6-.92-7.67h0A1.19,1.19,0,0,1,19,9.31h.4c.75,0,1.11.95,1.15,1.33h0a6,6,0,0,1-.22,1.68h0a4.1,4.1,0,0,0-.25-1.71h0c-.32-.69-.62-1.1-.88-1.17h0a.85.85,0,0,0-.32.64h0a9.59,9.59,0,0,0-.12,1.47h0a16.43,16.43,0,0,0,.68,4.28h0c.08-.24.16-.48.22-.7h0l.68-2.65h0s-.15,3.07-.36,4h0c0,.2-.09.39-.14.59h0a13.5,13.5,0,0,0,3.36,5.25h0a10.46,10.46,0,0,0,1.94,1.34h0a26.93,26.93,0,0,1,3.95-.3h0a5,5,0,0,1,3,.68h0a1.2,1.2,0,0,1,.33.76h0a2.6,2.6,0,0,1-.06.44h0c0-.08,0-.47-1.19-.86h0a14,14,0,0,0-4.84-.06h0c2.46,1.2,4.85,1.79,5.61,1.44h0a1.69,1.69,0,0,0,.41-.4h0a3.92,3.92,0,0,1-.23.76h0a1.2,1.2,0,0,1-.59.4h0c-1.2.32-4.31-.42-7-2h0a57.18,57.18,0,0,0-9,2.15h0c-2.63,4.6-4.6,6.71-6.21,5.91h0l-.59-.3a.69.69,0,0,1-.22-.74h0c.19-.92,1.34-2.3,3.65-3.67h0c.24-.16,1.35-.74,1.35-.74h0s-.82.79-1,1h0c-1.84,1.51-3.2,3.41-3.17,4.14h0v.07c1.56-.23,3.91-3.41,6.93-9.31m.95.49c-.5,1-1,1.83-1.45,2.63h0a38.68,38.68,0,0,1,7.8-2.2h0c-.35-.24-.68-.5-1-.76h0a13.42,13.42,0,0,1-3.29-4.28h0a35.21,35.21,0,0,1-2.06,4.61"></path> </symbol> <symbol id="zip" viewBox="0 0 40 40"> <path class="fill-zip-1" d="M32.17,1.09H1V38.77H39V7.44Z"></path> <polygon class="fill-zip-2" points="39 7.47 32.6 7.47 32.17 1.09 39 7.47"></polygon> <rect class="fill-zip-3" height="13.48" width="0.56" x="17.75" y="1.09"></rect> <rect class="fill-zip-3" height="13.48" width="0.56" x="21.69" y="1.09"></rect> <rect class="fill-zip-3" height="1.69" width="1.78" x="18.22" y="1.09"></rect> <rect class="fill-zip-3" height="1.69" width="1.78" x="20" y="2.77"></rect> <rect class="fill-zip-3" height="1.69" width="1.78" x="18.22" y="4.46"></rect> <rect class="fill-zip-3" height="1.69" width="1.78" x="20" y="6.15"></rect> <rect class="fill-zip-3" height="1.69" width="1.78" x="18.22" y="7.83"></rect> <rect class="fill-zip-3" height="1.69" width="1.78" x="20" y="9.52"></rect> <rect class="fill-zip-3" height="1.69" width="1.78" x="18.22" y="11.19"></rect> <rect class="fill-zip-3" height="1.69" width="1.78" x="20" y="12.87"></rect> <path class="fill-zip-3" d="M22.53,14.56H17.47a1,1,0,0,0-1,1V18.4a1,1,0,0,0,1,1h.84V16.51h3.38v2.85h.84a1,1,0,0,0,1-1V15.53A1,1,0,0,0,22.53,14.56Z"></path> <rect class="fill-zip-3" height="7.2" width="1.97" x="19.02" y="17.56"></rect> <path class="fill-zip-3" d="M22.32,22.67h-.63v4.19H18.31V22.67h-.63a1.14,1.14,0,0,0-1.13,1.14V35a1.13,1.13,0,0,0,1.13,1.13h4.64A1.13,1.13,0,0,0,23.45,35V23.81A1.14,1.14,0,0,0,22.32,22.67Zm-.63,11.38H18.31V31h3.38Z"></path> </symbol> <symbol id="word" viewBox="0 0 40 40"> <path class="word-fill-1" d="M20.86,1.5h2.58V5c4.62,0,9.23,0,13.85,0A1.49,1.49,0,0,1,39,6.63c.07,8.5,0,17,0,25.52a5,5,0,0,1-.42,2.61,3.93,3.93,0,0,1-2.18.43c-4.32,0-8.64,0-13,0v3.45h-2.7C14.17,37.43,7.59,36.32,1,35.17Q1,20.07,1,5C7.62,3.81,14.24,2.68,20.86,1.5Z"></path> <path class="word-fill-2" d="M23.44,6.25H37.69V33.88H23.44V30.42H34.67V28.7H23.44V26.54H34.67V24.81H23.44V22.65H34.67V20.93H23.44V18.77H34.67V17H23.44V14.88H34.67V13.16H23.44V11H34.67V9.27H23.44Z"></path> <path class="word-fill-2" d="M9.92,13.88l2.46-.13c.57,2.91,1.16,5.82,1.78,8.72.49-3,1-6,1.55-9,.86,0,1.73-.08,2.59-.13-1,4.18-1.83,8.4-2.9,12.56-.72.38-1.8,0-2.65,0-.57-2.86-1.24-5.7-1.76-8.57-.5,2.79-1.16,5.55-1.74,8.32l-2.5-.15C6,21.78,5.2,18,4.53,14.2l2.22-.09c.44,2.75.95,5.49,1.34,8.24C8.69,19.52,9.32,16.7,9.92,13.88Z"></path> </symbol> <symbol id="txt" viewBox="0 0 40 40"> <path class="fill-txt-1" d="M32.1,1.09H.67v38H39V7.5Z"></path> <polygon class="fill-txt-2" points="39 7.47 32.6 7.47 32.1 1.09 39 7.47"></polygon> <path class="fill-txt-3" d="M33.78,30.22h.92a2.13,2.13,0,0,0,2.13-2.13V17.27a2.13,2.13,0,0,0-2.13-2.13H5.3a2.13,2.13,0,0,0-2.13,2.13V28.09A2.13,2.13,0,0,0,5.3,30.22H33.78Z"></path> <polygon class="fill-txt-4" points="9.47 19.4 9.47 17.74 15.96 17.74 15.96 19.4 13.54 19.4 13.54 27.53 11.9 27.53 11.9 19.4 9.47 19.4"></polygon> <polygon class="fill-txt-4" points="16.45 17.74 18.38 17.74 20.02 20.89 21.62 17.74 23.53 17.74 20.99 22.5 23.78 27.53 21.79 27.53 19.98 24.15 18.17 27.53 16.19 27.53 18.98 22.43 16.45 17.74"></polygon> <polygon class="fill-txt-4" points="24.04 19.4 24.04 17.74 30.53 17.74 30.53 19.4 28.11 19.4 28.11 27.53 26.46 27.53 26.46 19.4 24.04 19.4"></polygon> </symbol> <symbol id="media" viewBox="0 0 40 40"> <circle class="media-fill-1" cx="20" cy="20" r="19"></circle> <circle class="media-fill-2" cx="20" cy="20" r="15"></circle> <polygon class="media-fill-3" points="28.96 20 15.04 12.5 15.04 27.5 28.96 20"></polygon> </symbol> <symbol id="info-circle" viewBox="0 0 40 40"> <path d="M20,0A20,20,0,1,0,40,20,20,20,0,0,0,20,0Zm3.14,27.36c-1.51,2.27-3,4-5.63,4-1.76-.29-2.49-1.55-2.1-2.84l3.32-11a.52.52,0,0,0-.3-.64c-.25-.08-.73.23-1.14.69l-2,2.42a10.92,10.92,0,0,1,0-1.35c1.51-2.27,4-4.05,5.67-4.05A2.26,2.26,0,0,1,23,17.48L19.67,28.54a.52.52,0,0,0,.31.58c.25.08.76-.23,1.18-.69l2-2.42A10.84,10.84,0,0,1,23.14,27.41ZM22.69,13a2.23,2.23,0,0,1-2.3-2.29,2.3,2.3,0,0,1,4.6,0A2.23,2.23,0,0,1,22.69,13Z" class="fr-evenodd"></path> </symbol> <symbol id="alert_06"> <path d="M15,0C6.8,0,0,6.8,0,15s6.8,15,15,15s15-6.8,15-15S23.3,0,15,0z M15,22.5c-0.8,0-1.5-0.7-1.5-1.5 s0.7-1.5,1.5-1.5s1.5,0.7,1.5,1.5S15.8,22.5,15,22.5z M16.5,16c0,0.8-0.7,1.5-1.5,1.5s-1.5-0.7-1.5-1.5V9c0-0.8,0.7-1.5,1.5-1.5 s1.5,0.7,1.5,1.5V16z"/> </symbol>  <symbol id="timelineicon"> <path d="M12,8A4,4 0 0,1 16,12A4,4 0 0,1 12,16A4,4 0 0,1 8,12A4,4 0 0,1 12,8M3.05,13H1V11H3.05C3.5,6.83 6.83,3.5 11,3.05V1H13V3.05C17.17,3.5 20.5,6.83 20.95,11H23V13H20.95C20.5,17.17 17.17,20.5 13,20.95V23H11V20.95C6.83,20.5 3.5,17.17 3.05,13M12,5A7,7 0 0,0 5,12A7,7 0 0,0 12,19A7,7 0 0,0 19,12A7,7 0 0,0 12,5Z" /> </symbol>  <symbol id="alert-circle" viewBox="0 0 24.00 24.00"> <path d="M 12.9994,12.998L 10.9994,12.998L 10.9994,6.99805L 12.9994,6.99805M 12.9994,16.998L 10.9994,16.998L 10.9994,14.998L 12.9994,14.998M 11.9994,1.99805C 6.47639,1.99805 1.99939,6.47504 1.99939,11.998C 1.99939,17.5211 6.47639,21.998 11.9994,21.998C 17.5224,21.998 21.9994,17.5211 21.9994,11.998C 21.9994,6.47504 17.5224,1.99805 11.9994,1.99805 Z "/> </symbol>  <symbol id="ext" viewBox="0 0 40 40"> <polygon points="36 17.97 36 36 4 36 4 4 22.03 4 22.03 1 1 1 1 39 39 39 39 17.97 36 17.97" /> <polygon points="39 1 26.27 1 31 5.73 17.52 19.21 20.8 22.48 34.27 9 39 13.73 39 1" /> </symbol> <symbol id="presentation_01" viewBox="0 0 40 40"> <path d="M35,5.21H5A1.29,1.29,0,1,1,5,2.63h13.7V1.34a1.3,1.3,0,0,1,2.6,0V2.63H35a1.29,1.29,0,1,1,0,2.58Zm0,20.64H5V6.5H35ZM9,15.57a5.2,5.2,0,0,0,10.4,0h-5.2V10.4A5.19,5.19,0,0,0,9,15.57Zm14.33-5.2H22v1.29h1.3Zm0,2.58H22v1.29h1.3Zm0,2.58H22v1.29h1.3Zm0,2.58H22V19.4h1.3Zm0,2.58H22V22h1.3Zm7.78-10.32H24.58v1.29h6.48Zm0,2.58H24.58v1.29h6.48Zm0,2.58H24.58v1.29h6.48Zm0,2.58H24.58V19.4h6.48Zm0,2.58H24.58V22h6.48ZM16.46,32.31h2.93V25.85h1.3v6.45h2.88l-2.88-6.45h2.6l5.18,11.61H25.88L24.15,33.6H20.69V40h-1.3V33.6H15.88l-1.76,3.87H11.53L16.8,25.85h2.59Zm4.22-6.45Zm-1.3,0Z" class="fill-a"></path> </symbol> <symbol id="excel" viewBox="0 0 40 40"> <path class="fill-excel-1" d="M20.87,1.5h2.56V5c4.32,0,8.64,0,13,0a4,4,0,0,1,2.17.41A4,4,0,0,1,39,7.54Q39,18.78,39,30a19.69,19.69,0,0,1-.15,3.78c-.17.9-1.25.92-2,.95-4.47,0-8.95,0-13.43,0v3.89H20.76C14.18,37.43,7.59,36.32,1,35.17V5C7.63,3.81,14.25,2.67,20.87,1.5Z"></path> <path class="fill-excel-2" d="M23.44,6.25H37.68v27.2H23.44V30.85h3.45v-3H23.44V26.11h3.45v-3H23.44V21.36h3.45v-3H23.44V16.61h3.45v-3H23.44V11.86h3.45v-3H23.44Z"></path> <path class="fill-excel-1" d="M28.62,8.84h6v3h-6Z"></path> <path class="fill-excel-2" d="M13.79,12.88q1.46-.1,2.94-.18Q15,16.25,13.24,19.78c1.19,2.42,2.4,4.82,3.59,7.23l-3.12-.2a51,51,0,0,1-2.15-5.42c-.59,1.75-1.42,3.41-2.1,5.12-.95,0-1.89-.05-2.84-.09,1.11-2.17,2.18-4.36,3.32-6.52-1-2.22-2-4.4-3-6.61l2.85-.16c.64,1.69,1.35,3.35,1.88,5.08C12.21,16.38,13.06,14.66,13.79,12.88Z"></path> <path class="fill-excel-1" d="M28.62,13.59h6v3h-6Z"></path> <path class="fill-excel-1" d="M28.62,18.34h6v3h-6Z"></path> <path class="fill-excel-1" d="M28.62,23.08h6v3h-6Z"></path> <path class="fill-excel-1" d="M28.62,27.83h6v3h-6Z"></path> </symbol> <symbol id="epub" viewBox="0 0 40 40"> <path class="fill-epub-1" d="M32.64,1H1.45V38.68h38V7.36Z"></path> <polygon class="fill-epub-2" points="39.47 7.39 33.07 7.39 32.64 1 39.47 7.39"></polygon> <path class="fill-epub-3" d="M20,27.23,12.77,20,20,12.77l2.41,2.41L17.59,20,20,22.41l7.23-7.23-6.3-6.29a1.3,1.3,0,0,0-1.86,0L8.89,19.07a1.3,1.3,0,0,0,0,1.86L19.07,31.11a1.3,1.3,0,0,0,1.86,0L31.11,20.93a1.3,1.3,0,0,0,0-1.86l-1.47-1.48Z"></path> </symbol> <symbol id="imgft" viewBox="0 0 40 40"> <path class="fill-svgimgfile" d="M32.58,1H1.39V38.68h38V7.36Z"></path> <polygon class="fill-op-2" points="39.41 7.39 33.01 7.39 32.58 1 39.41 7.39"></polygon> <path class="fill-w" d="M8.52,15.32a4,4,0,1,1,4,4A4,4,0,0,1,8.52,15.32ZM33.27,33.25H7.73V29.18l4.79-4.07,3.19,2.71,9.58-8.14,8,6.78Z"></path> </symbol> <symbol id="sas" viewBox="0 0 40 40"> <title>SAS</title> <path class="fill-sas" d="M32.58,1H1.39V38.68h38V7.36Zm-15,6.32A10.77,10.77,0,0,1,20.38,7a8.72,8.72,0,0,1,8.22,5.71C26.85,9.84,21.74,9.22,19,11c-3.16,2-4.2,5.47-1.87,8.3,0,0,1.32,1.61,2.48,3,.24.29.29.33.52.61h0l.36.44a1.74,1.74,0,0,1-2.66,2.22l-.9-1.1-3.2-3.87C8.31,14.06,13.22,8.42,17.61,7.32Zm4.78,25.36c-5.06,1.27-9.63-1.37-11-5.39C13.15,30.16,18.26,30.78,21,29c3.16-2,4.2-5.46,1.87-8.29l-3.23-3.9c-.13-.15-.2-.25-.2-.25a1.61,1.61,0,0,1,.34-2.32A1.84,1.84,0,0,1,21,13.83a1.51,1.51,0,0,1,1.11.55l.43.54,3.75,4.53C31.69,26,26.78,31.58,22.39,32.68Z"></path> <polygon style="opacity: 0.2;" points="39.41 7.39 33.01 7.39 32.58 1 39.41 7.39"></polygon> </symbol> <symbol id="stats" viewBox="0 0 40 40"> <title>stats</title> <path class="fill-txt-3" d="M32.58,1H1.39V38.68h38V7.36ZM27.22,14.61h4V29.12h-4Zm-6,3.46h4V29.12h-4Zm-6-11h4v22.1h-4Zm-6,4.58h4V29.12h-4Zm25,21.61H6.2a1,1,0,0,1,0-2h28a1,1,0,0,1,0,2Z"></path> <polygon style="opacity: 0.3;" points="39.41 7.39 33.01 7.39 32.58 1 39.41 7.39"></polygon> </symbol> <symbol id="cdc-tv" viewBox="0 0 40 40"> <defs> <linearGradient id="linear-gradient" x1="-1374.15" y1="10.03" x2="-1354.09" y2="25.47" gradientTransform="matrix(-1, 0, 0, 1, -1343.57, 0)" gradientUnits="userSpaceOnUse"> <stop offset="0" stop-color="#b8bab9"></stop> <stop offset="1" stop-color="#414042"></stop> </linearGradient> </defs> <path d="M38.61,6.5H1.3A.29.29,0,0,0,1,6.78v23a.29.29,0,0,0,.29.29H18.48v.64a1.51,1.51,0,0,1-.15.67H11.08L8.77,32.81v.33H31.15v-.33l-2.3-1.41H21.62a1.72,1.72,0,0,1-.15-.72v-.59H38.61a.29.29,0,0,0,.29-.29v-23A.29.29,0,0,0,38.61,6.5Z"></path> <polygon style="fill:url(#linear-gradient);" points="37.78 7.61 2.13 7.61 2.13 28.92 37.78 28.8 37.78 7.61"></polygon> <rect class="fill-w" x="2.16" y="7.64" width="35.6" height="21.31"></rect> <rect class="fill-cdc-tv" x="2.12" y="7.51" width="35.8" height="21.57"></rect> <polygon class="fill-w" points="16.82 29.08 37.92 7.71 37.92 7.5 37.81 7.5 16.51 29.08 16.82 29.08"></polygon> <polygon class="fill-w" points="3.52 29.08 4.95 7.5 4.73 7.5 3.3 29.08 3.52 29.08"></polygon> <polygon class="fill-w" points="4.66 29.08 7.74 7.5 7.52 7.5 4.44 29.08 4.66 29.08"></polygon> <polygon class="fill-w" points="5.88 29.08 10.7 7.5 10.47 7.5 5.65 29.08 5.88 29.08"></polygon> <polygon class="fill-w" points="7.22 29.08 14.1 7.5 13.87 7.5 6.99 29.08 7.22 29.08"></polygon> <polygon class="fill-w" points="8.49 29.08 17.32 7.5 17.08 7.5 8.25 29.08 8.49 29.08"></polygon> <polygon class="fill-w" points="9.94 29.08 20.99 7.5 20.74 7.5 9.69 29.08 9.94 29.08"></polygon> <polygon class="fill-w" points="26.51 7.5 26.25 7.5 11.94 29.08 12.21 29.08 26.51 7.5"></polygon> <polygon class="fill-w" points="31.61 7.5 31.33 7.5 13.94 29.08 14.23 29.08 31.61 7.5"></polygon> <polygon class="fill-w" points="37.92 15.67 37.92 15.38 20.67 29.08 21.03 29.08 37.92 15.67"></polygon> <polygon class="fill-w" points="37.92 21.61 37.92 21.34 25.53 29.08 25.95 29.08 37.92 21.61"></polygon> <polygon class="fill-w" points="37.92 27.2 37.92 26.96 33.36 29.08 33.89 29.08 37.92 27.2"></polygon> <path class="fill-w" d="M10.14,22.51c-3.72,0-6.25-2.3-6.25-6a6,6,0,0,1,6.28-6.17,7,7,0,0,1,2.8.56v1.78a3.3,3.3,0,0,0-2.77-1.46c-2.24,0-3.51,2.06-3.51,5,0,3.13,1.19,5.35,3.75,5.35A4.3,4.3,0,0,0,13,20.66l.43.93A5.05,5.05,0,0,1,10.14,22.51Z"></path> <path class="fill-w" d="M22.31,16.43c0,4.6-2.83,4.92-5,4.92V11.44C19.53,11.44,22.31,11.71,22.31,16.43Zm-2.95,5.86a5.54,5.54,0,0,0,5.7-5.91c0-4.77-3.41-5.84-6-5.84H14.79V22.29Z"></path> <path class="fill-w" d="M32.69,22.51c-3.72,0-6.25-2.3-6.25-6a6,6,0,0,1,6.28-6.17,7,7,0,0,1,2.8.56v1.78a3.3,3.3,0,0,0-2.76-1.46c-2.25,0-3.52,2.06-3.52,5,0,3.13,1.19,5.35,3.75,5.35a4.3,4.3,0,0,0,2.53-.93l.43.93A5,5,0,0,1,32.69,22.51Z"></path> </symbol> <symbol id="flickr" viewBox="0 0 40 40"> <rect class="fill-flickr flr-bg" x="1" y="1" width="38" height="38" rx="6.23"></rect> <path class="fill-flickr flr-dot-1" d="M32.89,20a5.62,5.62,0,1,1-5.62-5.62A5.62,5.62,0,0,1,32.89,20Z"></path> <path class="fill-flickr flr-dot-2" d="M18.35,20a5.62,5.62,0,1,1-5.62-5.62A5.62,5.62,0,0,1,18.35,20Z"></path> </symbol>  <symbol id="pinterest" viewBox="0 0 40 40"> <circle class="fill-w" cx="20" cy="20" r="19"></circle> <path class="fill-pinterest" d="M20,1a19,19,0,0,0-6.92,36.69,18.15,18.15,0,0,1,.06-5.45l2.23-9.44A6.85,6.85,0,0,1,14.8,20c0-2.64,1.53-4.62,3.44-4.62A2.39,2.39,0,0,1,20.64,18c0,1.63-1,4.07-1.57,6.33a2.76,2.76,0,0,0,2.81,3.43c3.38,0,6-3.56,6-8.7,0-4.55-3.27-7.73-7.94-7.73a8.22,8.22,0,0,0-8.58,8.24A7.41,7.41,0,0,0,12.75,24a.57.57,0,0,1,.14.54c-.15.6-.47,1.9-.53,2.16s-.28.42-.64.25c-2.37-1.1-3.85-4.57-3.85-7.36,0-6,4.35-11.49,12.55-11.49,6.59,0,11.71,4.69,11.71,11,0,6.55-4.13,11.82-9.86,11.82a5.09,5.09,0,0,1-4.35-2.18s-1,3.62-1.18,4.51a21,21,0,0,1-2.37,5A19,19,0,1,0,20,1Z"></path> </symbol> <symbol id="social_govd" viewBox="0 0 40 40" xmlns:xlink="http://www.w3.org/1999/xlink"> <path d="M9.42,27.77h-3a5.23,5.23,0,0,1-2.6-.63A5.16,5.16,0,0,1,1,22.45C1,17.06,1,11.67,1,6.28A5.32,5.32,0,0,1,6.27,1c9.08,0,18.17,0,27.25,0A5.42,5.42,0,0,1,39,6.41q0,8,0,15.93a5.38,5.38,0,0,1-5.48,5.43H24.31a1.55,1.55,0,0,0-.93.28L6.93,39.19a1.2,1.2,0,0,1-2-.78,2,2,0,0,1,.22-.92q2-4.64,4.09-9.28Zm6.1-14,3.62,2.68a1.26,1.26,0,0,0,1.7,0l3.08-2.29.52-.38.16.17,4.31,5.19,4.14,5a.8.8,0,1,0,1.21-1l-6.73-8.11L25.74,12.8l.24-.19,8.62-6.4a1.28,1.28,0,1,0-1.53-2q-6.36,4.72-12.72,9.45a.5.5,0,0,1-.72,0q-5-3.77-10.11-7.51c-.91-.68-1.82-1.36-2.74-2a1.23,1.23,0,0,0-1.61.06,1.22,1.22,0,0,0-.3,1.51,2.1,2.1,0,0,0,.57.61l8.37,6.22.4.31-.21.28L6.26,22.4c-.22.27-.46.53-.66.81a.79.79,0,0,0,1.2,1A3,3,0,0,0,7,24l6.16-7.42Z" class="fill-govd"></path> </symbol>  <symbol id="social_round_bookmark" viewBox="0 0 40 40"> <path class="fill-bookmark" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM29.8,29.8a1.67,1.67,0,0,1-1.09,1.56,1.53,1.53,0,0,1-.67.12A1.84,1.84,0,0,1,26.78,31l-6.71-6.45L13.37,31a1.86,1.86,0,0,1-1.26.5,1.55,1.55,0,0,1-.67-.14,1.67,1.67,0,0,1-1.09-1.56V10.2a1.68,1.68,0,0,1,1.09-1.56,1.71,1.71,0,0,1,.67-.14H28a1.71,1.71,0,0,1,.67.14A1.68,1.68,0,0,1,29.8,10.2Z"></path> </symbol> <symbol id="social_round_cdc-tv" viewBox="0 0 40 40"> <path class="fill-cdc-tv" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1Zm14.3,28H21.12v1.39a1.21,1.21,0,0,0,.12.55h5.55L28.55,32v.24H11.36V32l1.78-1.09H18.7a1,1,0,0,0,.12-.51V29H5.63a.27.27,0,0,1-.27-.27V11.05a.27.27,0,0,1,.27-.27H34.29a.27.27,0,0,1,.26.27V28.73A.27.27,0,0,1,34.29,29Z"></path> <path class="fill-cdc-tv" d="M17.9,15.6v7.62c1.69,0,3.87-.25,3.87-3.79S19.63,15.6,17.9,15.6Z"></path> <path class="fill-cdc-tv" d="M6.79,12V27.77H33.12V12ZM12.41,24.1c-2.85,0-4.8-1.76-4.8-4.61a4.64,4.64,0,0,1,4.83-4.74,5.26,5.26,0,0,1,2.15.43v1.37a2.53,2.53,0,0,0-2.12-1.12c-1.73,0-2.7,1.58-2.7,3.86s.91,4.11,2.88,4.11a3.24,3.24,0,0,0,1.94-.72l.33.72A3.84,3.84,0,0,1,12.41,24.1Zm7.09-.17H16v-9h3.28c2,0,4.61.82,4.61,4.48A4.26,4.26,0,0,1,19.5,23.93Zm10.24.17c-2.86,0-4.8-1.76-4.8-4.61a4.63,4.63,0,0,1,4.82-4.74,5.26,5.26,0,0,1,2.15.43v1.37a2.53,2.53,0,0,0-2.12-1.12c-1.72,0-2.7,1.58-2.7,3.86S28,23.4,30,23.4a3.24,3.24,0,0,0,1.94-.72l.33.72A3.83,3.83,0,0,1,29.74,24.1Z"></path> </symbol> <symbol id="social_round_email" viewBox="0 0 40 40"> <path class="fill-email" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM32,11,20,20.71,8,11ZM8,13.56l6.58,5.33L8,26.06ZM8,29l8.11-8.85L20,23.29l3.87-3.14L32,29Zm24-2.94-6.58-7.17L32,13.56Z"></path> </symbol> <symbol id="social_round_fb" viewBox="0 0 40 40"> <circle class="fill-fb" cx="19.99" cy="20" r="19"></circle> <path class="fill-w" d="M30.9,24.42l.68-5.28H26.36V15.77c0-1.53.42-2.57,2.61-2.57h2.8V8.48a35.84,35.84,0,0,0-4.08-.21c-4,0-6.79,2.46-6.79,7v3.89H16.34v5.28H20.9V39a18.64,18.64,0,0,0,5.46-1.07V24.42Z"></path> </symbol> <symbol id="social_round_facebook" viewBox="0 0 40 40"> <circle class="fill-fb" cx="19.99" cy="20" r="19"></circle> <path class="fill-w" d="M30.9,24.42l.68-5.28H26.36V15.77c0-1.53.42-2.57,2.61-2.57h2.8V8.48a35.84,35.84,0,0,0-4.08-.21c-4,0-6.79,2.46-6.79,7v3.89H16.34v5.28H20.9V39a18.64,18.64,0,0,0,5.46-1.07V24.42Z"></path> </symbol> <symbol id="social_round_flickr" viewBox="0 0 40 40"> <circle class="fill-flickr flr-bg" cx="19.99" cy="20" r="19"></circle> <path class="fill-flickr flr-dot-1" d="M32.89,20a5.62,5.62,0,1,1-5.62-5.62A5.62,5.62,0,0,1,32.89,20Z"></path> <path class="fill-flickr flr-dot-2" d="M18.35,20a5.62,5.62,0,1,1-5.62-5.62A5.62,5.62,0,0,1,18.35,20Z"></path> </symbol> <svg id="social_round_googleplus" viewBox="0 0 40 40"> <path class="fill-googleplus" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM14.55,29.5A9.5,9.5,0,1,1,20.94,13c-2,1.88-1.92,2-2.71,2.77a5.39,5.39,0,0,0-3.68-1.38,5.64,5.64,0,0,0,0,11.28c3.08,0,4.33-1.32,5.13-3.76H14.55V18.12h9.12C24.3,22.67,22.39,29.5,14.55,29.5Zm17.11-8.84V24H29.31V20.66H25.93V18.31h3.38V15h2.35v3.3H35v2.35Z"></path> </svg> <symbol id="social_round_govd" viewBox="0 0 40 40"> <path class="fill-govd" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1Zm8.43,25.94H22.69a.93.93,0,0,0-.58.18l-10.27,7a.75.75,0,0,1-1.24-.49,1.2,1.2,0,0,1,.14-.57c.84-1.93,1.7-3.86,2.55-5.79,0-.08.06-.16.11-.27H11.56a3.28,3.28,0,0,1-1.63-.4,3.24,3.24,0,0,1-1.78-2.93c0-3.36,0-6.72,0-10.08a3.32,3.32,0,0,1,3.28-3.29c5.67,0,11.34,0,17,0a3.37,3.37,0,0,1,3.4,3.38q0,5,0,9.94A3.36,3.36,0,0,1,28.42,26.94Z"></path> <path class="fill-govd" d="M28.16,12.21l-7.94,5.9a.32.32,0,0,1-.45,0l-6.31-4.69c-.56-.42-1.13-.85-1.7-1.26a.79.79,0,0,0-1,0,.76.76,0,0,0-.18.94,1.44,1.44,0,0,0,.35.39l5.23,3.88.24.19-.13.17-4.83,5.82c-.14.17-.29.33-.42.51a.48.48,0,0,0,.1.67.47.47,0,0,0,.65,0,1.14,1.14,0,0,0,.15-.16c1.28-1.54,2.56-3.09,3.85-4.63.47-.58,1-1.15,1.45-1.74.77.56,1.51,1.12,2.25,1.67a.81.81,0,0,0,1.07,0l1.92-1.43.32-.24a.47.47,0,0,1,.1.11c.9,1.07,1.79,2.15,2.69,3.23l2.58,3.11a.5.5,0,1,0,.75-.65c-1.39-1.69-2.8-3.37-4.2-5.06l-1.11-1.34.15-.12,5.38-4a.8.8,0,1,0-.95-1.27Z"></path> </symbol> <symbol id="social_round_instagram" viewBox="0 0 40 40"> <circle style="fill:url(#svg_ig_1);" cx="20" cy="20" r="20"></circle> <circle style="fill:url(#svg_ig_2);" cx="20" cy="20" r="20"></circle> <path class="fill-w" d="M20,5.5c-4,0-4.5,0-6.1,0.1c-1.6,0.1-2.6,0.3-3.6,0.7C9.4,6.7,8.5,7.2,7.7,8C6.9,8.8,6.4,9.7,6,10.6c-0.4,0.9-0.6,2-0.7,3.6c-0.1,1.6-0.1,2.1-0.1,6.1s0,4.5,0.1,6.1C5.4,28,5.6,29,6,30c0.4,1,0.9,1.8,1.7,2.6c0.8,0.8,1.6,1.3,2.6,1.7c0.9,0.4,2,0.6,3.6,0.7c1.6,0.1,2.1,0.1,6.1,0.1c4,0,4.5,0,6.1-0.1c1.6-0.1,2.6-0.3,3.6-0.7c1-0.4,1.8-0.9,2.6-1.7c0.8-0.8,1.3-1.6,1.7-2.6c0.4-0.9,0.6-2,0.7-3.6c0.1-1.6,0.1-2.1,0.1-6.1s0-4.5-0.1-6.1c-0.1-1.6-0.3-2.6-0.7-3.6c-0.4-1-0.9-1.8-1.7-2.6c-0.8-0.8-1.6-1.3-2.6-1.7c-0.9-0.4-2-0.6-3.6-0.7C24.5,5.6,24,5.5,20,5.5L20,5.5z M18.7,8.2c0.4,0,0.8,0,1.3,0c3.9,0,4.4,0,6,0.1c1.4,0.1,2.2,0.3,2.7,0.5c0.7,0.3,1.2,0.6,1.7,1.1c0.5,0.5,0.8,1,1.1,1.7c0.2,0.5,0.4,1.3,0.5,2.7c0.1,1.6,0.1,2,0.1,6s0,4.4-0.1,6c-0.1,1.4-0.3,2.2-0.5,2.7c-0.3,0.7-0.6,1.2-1.1,1.7c-0.5,0.5-1,0.8-1.7,1.1c-0.5,0.2-1.3,0.4-2.7,0.5c-1.6,0.1-2,0.1-6,0.1c-3.9,0-4.4,0-6-0.1c-1.4-0.1-2.2-0.3-2.7-0.5c-0.7-0.3-1.2-0.6-1.7-1.1c-0.5-0.5-0.8-1-1.1-1.7C8.3,28.5,8,27.7,8,26.3c-0.1-1.6-0.1-2-0.1-6s0-4.4,0.1-6c0.1-1.4,0.3-2.2,0.5-2.7c0.3-0.7,0.6-1.2,1.1-1.7c0.5-0.5,1-0.8,1.7-1.1c0.5-0.2,1.3-0.4,2.7-0.5C15.4,8.2,15.9,8.2,18.7,8.2L18.7,8.2z M27.9,10.7c-1,0-1.8,0.8-1.8,1.8c0,1,0.8,1.8,1.8,1.8s1.8-0.8,1.8-1.8S28.9,10.7,27.9,10.7L27.9,10.7z M20,12.7c-4.2,0-7.6,3.4-7.6,7.6s3.4,7.6,7.6,7.6c4.2,0,7.6-3.4,7.6-7.6S24.2,12.7,20,12.7L20,12.7z M20,15.4c2.7,0,4.9,2.2,4.9,4.9c0,2.7-2.2,4.9-4.9,4.9c-2.7,0-4.9-2.2-4.9-4.9C15.1,17.6,17.3,15.4,20,15.4z"></path> </symbol> <symbol id="social_round_ig" viewBox="0 0 40 40"> <circle style="fill:url(#svg_ig_1);" cx="20" cy="20" r="20"></circle> <circle style="fill:url(#svg_ig_2);" cx="20" cy="20" r="20"></circle> <path class="fill-w" d="M20,5.5c-4,0-4.5,0-6.1,0.1c-1.6,0.1-2.6,0.3-3.6,0.7C9.4,6.7,8.5,7.2,7.7,8C6.9,8.8,6.4,9.7,6,10.6c-0.4,0.9-0.6,2-0.7,3.6c-0.1,1.6-0.1,2.1-0.1,6.1s0,4.5,0.1,6.1C5.4,28,5.6,29,6,30c0.4,1,0.9,1.8,1.7,2.6c0.8,0.8,1.6,1.3,2.6,1.7c0.9,0.4,2,0.6,3.6,0.7c1.6,0.1,2.1,0.1,6.1,0.1c4,0,4.5,0,6.1-0.1c1.6-0.1,2.6-0.3,3.6-0.7c1-0.4,1.8-0.9,2.6-1.7c0.8-0.8,1.3-1.6,1.7-2.6c0.4-0.9,0.6-2,0.7-3.6c0.1-1.6,0.1-2.1,0.1-6.1s0-4.5-0.1-6.1c-0.1-1.6-0.3-2.6-0.7-3.6c-0.4-1-0.9-1.8-1.7-2.6c-0.8-0.8-1.6-1.3-2.6-1.7c-0.9-0.4-2-0.6-3.6-0.7C24.5,5.6,24,5.5,20,5.5L20,5.5z M18.7,8.2c0.4,0,0.8,0,1.3,0c3.9,0,4.4,0,6,0.1c1.4,0.1,2.2,0.3,2.7,0.5c0.7,0.3,1.2,0.6,1.7,1.1c0.5,0.5,0.8,1,1.1,1.7c0.2,0.5,0.4,1.3,0.5,2.7c0.1,1.6,0.1,2,0.1,6s0,4.4-0.1,6c-0.1,1.4-0.3,2.2-0.5,2.7c-0.3,0.7-0.6,1.2-1.1,1.7c-0.5,0.5-1,0.8-1.7,1.1c-0.5,0.2-1.3,0.4-2.7,0.5c-1.6,0.1-2,0.1-6,0.1c-3.9,0-4.4,0-6-0.1c-1.4-0.1-2.2-0.3-2.7-0.5c-0.7-0.3-1.2-0.6-1.7-1.1c-0.5-0.5-0.8-1-1.1-1.7C8.3,28.5,8,27.7,8,26.3c-0.1-1.6-0.1-2-0.1-6s0-4.4,0.1-6c0.1-1.4,0.3-2.2,0.5-2.7c0.3-0.7,0.6-1.2,1.1-1.7c0.5-0.5,1-0.8,1.7-1.1c0.5-0.2,1.3-0.4,2.7-0.5C15.4,8.2,15.9,8.2,18.7,8.2L18.7,8.2z M27.9,10.7c-1,0-1.8,0.8-1.8,1.8c0,1,0.8,1.8,1.8,1.8s1.8-0.8,1.8-1.8S28.9,10.7,27.9,10.7L27.9,10.7z M20,12.7c-4.2,0-7.6,3.4-7.6,7.6s3.4,7.6,7.6,7.6c4.2,0,7.6-3.4,7.6-7.6S24.2,12.7,20,12.7L20,12.7z M20,15.4c2.7,0,4.9,2.2,4.9,4.9c0,2.7-2.2,4.9-4.9,4.9c-2.7,0-4.9-2.2-4.9-4.9C15.1,17.6,17.3,15.4,20,15.4z"></path> </symbol> <symbol id="social_round_linkedin" viewBox="0 0 40 40"> <path class="fill-linkin" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM13.58,31H8.92V16h4.66ZM11.25,14a2.7,2.7,0,1,1,2.7-2.7A2.7,2.7,0,0,1,11.25,14ZM31,31H26.36V23.73c0-1.73,0-4-2.42-4s-2.79,1.9-2.79,3.85V31H16.5V16H21v2.05H21a4.88,4.88,0,0,1,4.4-2.42c4.72,0,5.59,3.1,5.59,7.13Z"></path> </symbol> <symbol id="social_round_pinterest" viewBox="0 0 40 40"> <circle class="fill-w" cx="20" cy="20" r="19"></circle> <path class="fill-pinterest" d="M20,1a19,19,0,0,0-6.92,36.69,18.15,18.15,0,0,1,.06-5.45l2.23-9.44A6.85,6.85,0,0,1,14.8,20c0-2.64,1.53-4.62,3.44-4.62A2.39,2.39,0,0,1,20.64,18c0,1.63-1,4.07-1.57,6.33a2.76,2.76,0,0,0,2.81,3.43c3.38,0,6-3.56,6-8.7,0-4.55-3.27-7.73-7.94-7.73a8.22,8.22,0,0,0-8.58,8.24A7.41,7.41,0,0,0,12.75,24a.57.57,0,0,1,.14.54c-.15.6-.47,1.9-.53,2.16s-.28.42-.64.25c-2.37-1.1-3.85-4.57-3.85-7.36,0-6,4.35-11.49,12.55-11.49,6.59,0,11.71,4.69,11.71,11,0,6.55-4.13,11.82-9.86,11.82a5.09,5.09,0,0,1-4.35-2.18s-1,3.62-1.18,4.51a21,21,0,0,1-2.37,5A19,19,0,1,0,20,1Z"></path> </symbol> <symbol id="social_round_podcast" viewBox="0 0 40 40"> <path class="fill-podcast" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1Zm2.8,33.33a.67.67,0,0,1-.67.67H17.84a.67.67,0,0,1-.67-.67V23.2a.67.67,0,0,1,.67-.67h4.28a.67.67,0,0,1,.67.67ZM17.27,19.16A2.73,2.73,0,1,1,20,21.89,2.73,2.73,0,0,1,17.27,19.16Zm8,4.37a6.89,6.89,0,1,0-10.59-.16l-.44,2a8.61,8.61,0,1,1,11.54.05Zm1.56,5.72-.49-1.74-.08-.28a10.19,10.19,0,1,0-12.42,0l-.12.58-.35,1.5a12.16,12.16,0,1,1,13.46-.08Z"></path> </symbol> <symbol id="social_round_rss" viewBox="0 0 40 40"> <path class="fill-rss" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM12.08,31.06a3.14,3.14,0,1,1,3.13-3.14A3.14,3.14,0,0,1,12.08,31.06Zm11.22-.34a1,1,0,0,1-.77.34h-2.2a1,1,0,0,1-1-.95A10.46,10.46,0,0,0,9.89,20.7a1,1,0,0,1-1-1v-2.2a1,1,0,0,1,.34-.77,1,1,0,0,1,.71-.28h.08A14.79,14.79,0,0,1,23.58,29.93,1.1,1.1,0,0,1,23.3,30.72Zm8.35,0a1,1,0,0,1-.76.33H28.56a1.05,1.05,0,0,1-1-1A18.7,18.7,0,0,0,9.92,12.47a1,1,0,0,1-1-1V9.1a1,1,0,0,1,.33-.75A1,1,0,0,1,10,8.06h0A23.2,23.2,0,0,1,31.94,30,1,1,0,0,1,31.65,30.73Z"></path> </symbol> <symbol id="social_round_syndication" viewBox="0 0 40 40"> <path class="fill-synd" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1Zm1.33,9.94a1,1,0,0,1,1.27-.71,10.47,10.47,0,0,1,2.37,1,10.11,10.11,0,0,1,4.83,6.42A1,1,0,0,1,29,18.89a1,1,0,0,1-1.24-.75A8.17,8.17,0,0,0,22,12.21,1,1,0,0,1,21.32,10.94Zm8,12.86a9,9,0,0,1-.66,1.36,10.13,10.13,0,0,1-7.55,5H21a1,1,0,0,1-1-.89,1,1,0,0,1,.89-1.15,8.1,8.1,0,0,0,6-4A7.31,7.31,0,0,0,27.45,23a1,1,0,0,1,1.91.76Zm-9-8.72a1,1,0,0,1,1.3-.66,5.91,5.91,0,0,1,3.85,3.94,1,1,0,0,1-.68,1.27,1,1,0,0,1-1.29-.69,3.86,3.86,0,0,0-2.52-2.57A1,1,0,0,1,20.39,15.08Zm-1.76.12a1,1,0,0,1-.48,1.37,4,4,0,0,0-2.1,2.67,1,1,0,0,1-1,.81.83.83,0,0,1-.22,0A1,1,0,0,1,14,18.8a6,6,0,0,1,3.22-4.07A1,1,0,0,1,18.63,15.2Zm-.8-4.15a1,1,0,0,1-.64,1.31A8.14,8.14,0,0,0,12.78,16a8,8,0,0,0-1,2.72,1,1,0,0,1-1,.85h-.18a1,1,0,0,1-.84-1.18A10,10,0,0,1,11,15a10.2,10.2,0,0,1,5.53-4.54A1,1,0,0,1,17.83,11.05ZM6.93,19H6.77a1,1,0,0,1-.86-1.17A14.11,14.11,0,0,1,14.84,6.9a1,1,0,0,1,1.33.6,1,1,0,0,1-.6,1.32,12.14,12.14,0,0,0-6.16,5.23A11.7,11.7,0,0,0,8,18.16,1,1,0,0,1,6.93,19Zm7.37,6.31-6-.84L19.8,19.85,15.2,31.23Zm6.12-1.44a3.89,3.89,0,0,0,2.94-2.17,1,1,0,0,1,1.38-.49,1,1,0,0,1,.49,1.37,5.93,5.93,0,0,1-4.51,3.32h-.15a1,1,0,0,1-.15-2Zm12.51,1.46a14.92,14.92,0,0,1-.86,1.75,14.11,14.11,0,0,1-11.24,7h-.07a1,1,0,0,1-.07-2.05A12,12,0,0,0,31,24.58a1,1,0,0,1,1.91.77ZM32.8,18a1,1,0,0,1-.24,0,1,1,0,0,1-1-.78,11.93,11.93,0,0,0-5.68-7.55,12.09,12.09,0,0,0-3-1.22,1,1,0,0,1-.73-1.26,1,1,0,0,1,1.26-.73,14.12,14.12,0,0,1,3.46,1.43,14,14,0,0,1,6.65,8.84A1,1,0,0,1,32.8,18Z"></path> </symbol> <symbol id="social_round_tumblr" viewBox="0 0 40 40"> <path class="fill-tumblr" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1Zm7.59,29.88a7.34,7.34,0,0,1-4.74,1.6h-.2c-6.14,0-7.47-4.5-7.47-7.14V18H12.75a.5.5,0,0,1-.5-.51V14.07a.86.86,0,0,1,.57-.81A6.46,6.46,0,0,0,17.1,7.31c0-.55.33-.83.82-.83h3.6A.51.51,0,0,1,22,7v5.85h4.21a.51.51,0,0,1,.51.51V17.5a.5.5,0,0,1-.51.5H22v6.77a1.89,1.89,0,0,0,1.81,2.16,5,5,0,0,0,1.64-.35,1.13,1.13,0,0,1,.65-.11c.18,0,.29.17.37.4l1.12,3.26C27.69,30.39,27.77,30.68,27.58,30.88Z"></path> </symbol> <symbol id="social_round_twitter" viewBox="0 0 40 40"> <circle class="fill-tw" cx="19.99" cy="20" r="19"></circle> <path class="fill-w" d="M15.59,29.65A13.77,13.77,0,0,0,29.46,15.79c0-.21,0-.42,0-.63a10,10,0,0,0,2.44-2.53,9.85,9.85,0,0,1-2.8.77,4.9,4.9,0,0,0,2.14-2.69,10,10,0,0,1-3.09,1.18,4.87,4.87,0,0,0-8.43,3.33,5,5,0,0,0,.12,1.11,13.8,13.8,0,0,1-10-5.09,4.88,4.88,0,0,0,1.51,6.51,5,5,0,0,1-2.21-.61v.06A4.88,4.88,0,0,0,13,22a5,5,0,0,1-1.29.17,4.53,4.53,0,0,1-.91-.09,4.87,4.87,0,0,0,4.55,3.38,9.77,9.77,0,0,1-6.05,2.09,8.82,8.82,0,0,1-1.16-.07,13.77,13.77,0,0,0,7.46,2.19"></path> </symbol> <symbol id="social_round_youtube" viewBox="0 0 40 40"> <path class="fill-youtube" d="M20,1A19,19,0,1,0,39,20,19,19,0,0,0,20,1ZM13.85,27V13l12.3,7Z"></path> </symbol> <symbol id="intranet-connects-cdc"> <style type="text/css"> .st0 { fill: #FFFFFF; } .st1 { fill: none; stroke: #FFFFFF; stroke-width: 2.1206; } .st2 { fill: #005DA9; } .st3 { fill: none; stroke: #FFFFFF; stroke-width: 1.8943; } .st4 { fill: #607171; } </style> <g> <rect x="1.3" y="9.6" class="st0" width="157.9" height="96.4"/> <rect x="1.3" y="9.6" class="st1" width="157.9" height="96.4"/> <rect x="2.8" y="11" class="st2" width="155" height="93.4"/> <polygon class="st0" points="66.5,104.5 157.8,11.9 157.8,11 157.3,11 65.1,104.5 "/> <polygon class="st0" points="8.8,104.5 15,11 14.1,11 7.9,104.5 "/> <polygon class="st0" points="13.8,104.5 27.1,11 26.1,11 12.8,104.5 "/> <polygon class="st0" points="19.1,104.5 39.9,11 39,11 18.1,104.5 "/> <polygon class="st0" points="24.9,104.5 54.7,11 53.7,11 23.9,104.5 "/> <polygon class="st0" points="30.4,104.5 68.6,11 67.6,11 29.3,104.5 "/> <polygon class="st0" points="36.7,104.5 84.5,11 83.4,11 35.6,104.5 "/> <polygon class="st0" points="108.4,11 107.3,11 45.3,104.5 46.5,104.5 "/> <polygon class="st0" points="130.5,11 129.3,11 54,104.5 55.2,104.5 "/> <polygon class="st0" points="157.8,46.4 157.8,45.2 83.1,104.5 84.7,104.5 "/> <polygon class="st0" points="157.8,72.1 157.8,71 104.2,104.5 106,104.5 "/> <polygon class="st0" points="157.8,96.4 157.8,95.3 138.1,104.5 140.3,104.5 "/> <g> <path class="st0" d="M37.5,76C21.4,76,10.4,66.1,10.4,50c0-15.7,11.7-26.7,27.2-26.7c4.1,0,8.7,0.8,12.2,2.4v7.7 c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1 C49.5,73.7,45.6,76,37.5,76"/> <path class="st3" d="M37.5,76C21.4,76,10.4,66.1,10.4,50c0-15.7,11.7-26.7,27.2-26.7c4.1,0,8.7,0.8,12.2,2.4v7.7 c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1 C49.5,73.7,45.6,76,37.5,76z"/> <path class="st0" d="M77.4,75.1c9.8,0,24.7-6.1,24.7-25.6c0-20.7-14.8-25.3-26-25.3H57.6v50.9H77.4z M90.2,49.7 C90.2,69.6,78,71,68.4,71V28C78.2,28,90.2,29.2,90.2,49.7"/> <path class="st3" d="M77.4,75.1c9.8,0,24.7-6.1,24.7-25.6c0-20.7-14.8-25.3-26-25.3H57.6v50.9H77.4z M90.2,49.7 C90.2,69.6,78,71,68.4,71V28C78.2,28,90.2,29.2,90.2,49.7z"/> <path class="st0" d="M135.2,76c-16.1,0-27.1-9.9-27.1-26.1c0-15.7,11.7-26.7,27.2-26.7c4.2,0,8.7,0.8,12.2,2.4v7.7 c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1 C147.2,73.7,143.2,76,135.2,76"/> <path class="st3" d="M135.2,76c-16.1,0-27.1-9.9-27.1-26.1c0-15.7,11.7-26.7,27.2-26.7c4.2,0,8.7,0.8,12.2,2.4v7.7 c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1 C147.2,73.7,143.2,76,135.2,76z"/> </g> </g> <circle fill="transparent" cx="291.9" cy="61.5" r="30.6"/> <path class="st4" d="M267.9,97.4c-8.5,8-20,12.9-32.6,12.9c-26.3,0-47.8-21.4-47.8-47.8c0-26.3,21.4-47.8,47.8-47.8 c12.6,0,24,4.9,32.6,12.9c3.7-2.6,7.9-4.7,12.4-6C269.1,9.4,253.1,1.7,235.3,1.7c-33.5,0-60.8,27.3-60.8,60.8s27.3,60.8,60.8,60.8 c17.8,0,33.8-7.7,44.9-19.9C275.8,102,271.6,100,267.9,97.4z"/> <g> <path class="st4" d="M255.5,62.4c0-20.4,16.5-36.9,37-36.9c20.4,0,37,16.5,37,36.9c0,20.5-16.5,37-37,37 C272,99.5,255.5,83,255.5,62.4z M316.4,62.5c0-13.6-10.7-24.6-24-24.6c-13.2,0-24,11-24,24.6c0,13.7,10.7,24.7,24,24.7 C305.7,87.2,316.4,76.1,316.4,62.5z"/> <path class="st4" d="M404.9,57.2V98h-13V60.3c0-12.4-9.7-22.5-21.8-22.5c-12,0-21.8,10.1-21.8,22.5V98h-13V27h13v10.5 c5.8-7.3,14.8-12,24.8-12C390.7,25.5,404.9,39.7,404.9,57.2z"/> <path class="st4" d="M482.9,57.2V98h-13V60.3c0-12.4-9.7-22.5-21.8-22.5c-12,0-21.8,10.1-21.8,22.5V98h-13V27h13v10.5 c5.8-7.3,14.8-12,24.8-12C468.7,25.5,482.9,39.7,482.9,57.2z"/> <path class="st4" d="M526.7,87.2c8.3,0,18.1-2.9,25.7-7.3l5.6,10.9c-9.4,5.4-20.9,8.7-31.3,8.7c-22.3,0-37.4-14.3-37.5-37 c0-20.4,15.9-37,35.5-37c19.6,0,35.5,16.5,35.5,36.9c0,2.4-0.3,4.8-0.7,7.1H503C505.5,80.9,514.3,87.2,526.7,87.2z M546.8,57.5 c-2.1-11.2-11.2-19.7-22.1-19.7c-10.9,0-20,8.5-22.1,19.7H546.8z"/> <path class="st4" d="M622.7,77.1l8.9,8.2c-6.7,8.5-17.2,14-29,14c-20.4,0-37-16.5-37-36.9c0-20.4,16.5-36.9,37-36.9 c11.8,0,22.2,5.5,29,14l-8.9,8.2c-4.5-5.6-12-9.9-20-9.9c-13.1,0-24,11-24,24.6c0,13.6,10.9,24.6,24,24.6 C610.8,87.1,618.2,82.8,622.7,77.1z"/> <path class="st4" d="M689,95.8c-10.7,4.7-22.8,5.3-31.4,0c-6.2-3.8-10-10.4-10-19.6V39.3H634V27h13.6V7.1h13V27h22.7v12.3h-22.7 v35.5c0,4.9,1.4,8.4,4.5,10.4c4.9,3,12.9,1.9,20.1-0.9L689,95.8z"/> <path class="st4" d="M690.5,89.6l5.7-10.3c4.6,2.9,13.8,7.6,24.9,7.5c8.3-0.1,16.2-2.9,16.1-8.5c-0.1-6.5-8-8-15.5-9.3 c-13.2-2.4-27.8-6.8-27.9-22.4c-0.1-14.9,15.6-21.3,28.4-21.4c9.7-0.1,21.6,4.3,29.5,9.7L746,45.1c-5.1-3.6-15.1-7.6-23.6-7.5 c-8.8,0.1-14.5,3.5-14.4,8.6c0.1,6.8,7.5,8.5,13.8,9.8c15.7,3.1,29.5,6.8,29.6,21.6c0.1,15.8-18,21.6-29.9,21.6 C711.1,99.3,698.6,94.9,690.5,89.6z"/> </g> </symbol> <symbol id="intranet-connects-text"> <style type="text/css"> .st0 { fill: #FFFFFF; } .st1 { fill: none; stroke: #FFFFFF; stroke-width: 2.1206; } .st2 { fill: #005DA9; } .st3 { fill: none; stroke: #FFFFFF; stroke-width: 1.8943; } .st4 { fill: #607171; } </style> <g> <rect x="1.3" y="9.6" class="st0" width="157.9" height="96.4"/> <rect x="1.3" y="9.6" class="st1" width="157.9" height="96.4"/> <rect x="2.8" y="11" class="st2" width="155" height="93.4"/> <polygon class="st0" points="66.5,104.5 157.8,11.9 157.8,11 157.3,11 65.1,104.5 "/> <polygon class="st0" points="8.8,104.5 15,11 14.1,11 7.9,104.5 "/> <polygon class="st0" points="13.8,104.5 27.1,11 26.1,11 12.8,104.5 "/> <polygon class="st0" points="19.1,104.5 39.9,11 39,11 18.1,104.5 "/> <polygon class="st0" points="24.9,104.5 54.7,11 53.7,11 23.9,104.5 "/> <polygon class="st0" points="30.4,104.5 68.6,11 67.6,11 29.3,104.5 "/> <polygon class="st0" points="36.7,104.5 84.5,11 83.4,11 35.6,104.5 "/> <polygon class="st0" points="108.4,11 107.3,11 45.3,104.5 46.5,104.5 "/> <polygon class="st0" points="130.5,11 129.3,11 54,104.5 55.2,104.5 "/> <polygon class="st0" points="157.8,46.4 157.8,45.2 83.1,104.5 84.7,104.5 "/> <polygon class="st0" points="157.8,72.1 157.8,71 104.2,104.5 106,104.5 "/> <polygon class="st0" points="157.8,96.4 157.8,95.3 138.1,104.5 140.3,104.5 "/> <g> <path class="st0" d="M37.5,76C21.4,76,10.4,66.1,10.4,50c0-15.7,11.7-26.7,27.2-26.7c4.1,0,8.7,0.8,12.2,2.4v7.7 c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1 C49.5,73.7,45.6,76,37.5,76"/> <path class="st3" d="M37.5,76C21.4,76,10.4,66.1,10.4,50c0-15.7,11.7-26.7,27.2-26.7c4.1,0,8.7,0.8,12.2,2.4v7.7 c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1 C49.5,73.7,45.6,76,37.5,76z"/> <path class="st0" d="M77.4,75.1c9.8,0,24.7-6.1,24.7-25.6c0-20.7-14.8-25.3-26-25.3H57.6v50.9H77.4z M90.2,49.7 C90.2,69.6,78,71,68.4,71V28C78.2,28,90.2,29.2,90.2,49.7"/> <path class="st3" d="M77.4,75.1c9.8,0,24.7-6.1,24.7-25.6c0-20.7-14.8-25.3-26-25.3H57.6v50.9H77.4z M90.2,49.7 C90.2,69.6,78,71,68.4,71V28C78.2,28,90.2,29.2,90.2,49.7z"/> <path class="st0" d="M135.2,76c-16.1,0-27.1-9.9-27.1-26.1c0-15.7,11.7-26.7,27.2-26.7c4.2,0,8.7,0.8,12.2,2.4v7.7 c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1 C147.2,73.7,143.2,76,135.2,76"/> <path class="st3" d="M135.2,76c-16.1,0-27.1-9.9-27.1-26.1c0-15.7,11.7-26.7,27.2-26.7c4.2,0,8.7,0.8,12.2,2.4v7.7 c-1.7-2.3-5.2-6.3-12-6.3c-9.7,0-15.2,8.9-15.2,21.8c0,13.5,5.1,23.2,16.2,23.2c3.9,0,8.8-2,11-4.1l1.8,4.1 C147.2,73.7,143.2,76,135.2,76z"/> </g> </g> <circle fill="transparent" cx="291.9" cy="61.5" r="30.6"/> <path class="st4" d="M267.9,97.4c-8.5,8-20,12.9-32.6,12.9c-26.3,0-47.8-21.4-47.8-47.8c0-26.3,21.4-47.8,47.8-47.8 c12.6,0,24,4.9,32.6,12.9c3.7-2.6,7.9-4.7,12.4-6C269.1,9.4,253.1,1.7,235.3,1.7c-33.5,0-60.8,27.3-60.8,60.8s27.3,60.8,60.8,60.8 c17.8,0,33.8-7.7,44.9-19.9C275.8,102,271.6,100,267.9,97.4z"/> <g> <path class="st4" d="M255.5,62.4c0-20.4,16.5-36.9,37-36.9c20.4,0,37,16.5,37,36.9c0,20.5-16.5,37-37,37 C272,99.5,255.5,83,255.5,62.4z M316.4,62.5c0-13.6-10.7-24.6-24-24.6c-13.2,0-24,11-24,24.6c0,13.7,10.7,24.7,24,24.7 C305.7,87.2,316.4,76.1,316.4,62.5z"/> <path class="st4" d="M404.9,57.2V98h-13V60.3c0-12.4-9.7-22.5-21.8-22.5c-12,0-21.8,10.1-21.8,22.5V98h-13V27h13v10.5 c5.8-7.3,14.8-12,24.8-12C390.7,25.5,404.9,39.7,404.9,57.2z"/> <path class="st4" d="M482.9,57.2V98h-13V60.3c0-12.4-9.7-22.5-21.8-22.5c-12,0-21.8,10.1-21.8,22.5V98h-13V27h13v10.5 c5.8-7.3,14.8-12,24.8-12C468.7,25.5,482.9,39.7,482.9,57.2z"/> <path class="st4" d="M526.7,87.2c8.3,0,18.1-2.9,25.7-7.3l5.6,10.9c-9.4,5.4-20.9,8.7-31.3,8.7c-22.3,0-37.4-14.3-37.5-37 c0-20.4,15.9-37,35.5-37c19.6,0,35.5,16.5,35.5,36.9c0,2.4-0.3,4.8-0.7,7.1H503C505.5,80.9,514.3,87.2,526.7,87.2z M546.8,57.5 c-2.1-11.2-11.2-19.7-22.1-19.7c-10.9,0-20,8.5-22.1,19.7H546.8z"/> <path class="st4" d="M622.7,77.1l8.9,8.2c-6.7,8.5-17.2,14-29,14c-20.4,0-37-16.5-37-36.9c0-20.4,16.5-36.9,37-36.9 c11.8,0,22.2,5.5,29,14l-8.9,8.2c-4.5-5.6-12-9.9-20-9.9c-13.1,0-24,11-24,24.6c0,13.6,10.9,24.6,24,24.6 C610.8,87.1,618.2,82.8,622.7,77.1z"/> <path class="st4" d="M689,95.8c-10.7,4.7-22.8,5.3-31.4,0c-6.2-3.8-10-10.4-10-19.6V39.3H634V27h13.6V7.1h13V27h22.7v12.3h-22.7 v35.5c0,4.9,1.4,8.4,4.5,10.4c4.9,3,12.9,1.9,20.1-0.9L689,95.8z"/> <path class="st4" d="M690.5,89.6l5.7-10.3c4.6,2.9,13.8,7.6,24.9,7.5c8.3-0.1,16.2-2.9,16.1-8.5c-0.1-6.5-8-8-15.5-9.3 c-13.2-2.4-27.8-6.8-27.9-22.4c-0.1-14.9,15.6-21.3,28.4-21.4c9.7-0.1,21.6,4.3,29.5,9.7L746,45.1c-5.1-3.6-15.1-7.6-23.6-7.5 c-8.8,0.1-14.5,3.5-14.4,8.6c0.1,6.8,7.5,8.5,13.8,9.8c15.7,3.1,29.5,6.8,29.6,21.6c0.1,15.8-18,21.6-29.9,21.6 C711.1,99.3,698.6,94.9,690.5,89.6z"/> </g> </symbol> </svg>  <script>var MP = {  Version: '3.1.1.1', SrcLang: 'en',  UrlLang: 'mp_js_current_lang', SrcUrl: decodeURIComponent('mp_js_orgin_url'), oSite: decodeURIComponent('mp_js_origin_baseUrl'), tSite: decodeURIComponent('mp_js_translated_baseUrl'),  init: function() { if (MP.oSite.indexOf('p_js_') == 1) { MP.SrcUrl = window.top.document.location.href; MP.oSite = MP.tSite = window.top.document.location.host; MP.UrlLang = MP.SrcLang; } }, switchLanguage: function(url,pref,sync) { var sync = sync; var oSite=MP.oSite.replace('http://','').replace('https://','').replace(/\/?$/, ''); var tSite=MP.tSite.replace('http://','').replace('https://','').replace(/\/?$/, ''); url=url.replace('http://','').replace('https://','').replace(/\/?$/, ''); if(sync && (typeof MpStorage !== 'undefined')&&(typeof MpStorage.updatePref !== 'undefined')){ if(pref){ var lang = pref.substring(0, 2); pref = lang == MP.UrlLang ? MP.SrcLang+pref.substring(2):pref; } MpStorage.updatePref(url,pref); } setTimeout(function() { var script = document.createElement('SCRIPT'); if (url == oSite) { tSite = tSite.split(/[/?#]/)[0]; script.src = location.protocol + '//' + tSite +'?1023749634;' + encodeURIComponent(location.href); } else { url = url.split(/[/?#]/)[0]; script.src = location.protocol + '//' + url +'?1023749632;' + encodeURIComponent(MP.SrcUrl); } var target = document.getElementsByTagName('script')[0]; target.parentNode.insertBefore(script, target); }, 500); return false; }, switchToLang: function(url) { if(window.top.location.href == url){ if((typeof MpStorage !== 'undefined')&&(typeof MpStorage.updatePref !== 'undefined')) MpStorage.updatePref(MP.oSite,MP.SrcLang); }else{ window.top.location.href = url; } }  };</script><script>function switchLanguage(lang) { MP.UrlLang='mp_js_current_lang'; MP.SrcUrl=decodeURIComponent('mp_js_orgin_url'); MP.oSite=decodeURIComponent('mp_js_origin_baseUrl'); MP.tSite=decodeURIComponent('mp_js_translated_baseUrl'); MP.init(); } </script><script src="/TemplatePackage/contrib/libs/d3/d3.min.js"></script> <script src="/TemplatePackage/contrib/libs/c3/c3.js"></script> <script src="/TemplatePackage/contrib/libs/mmwr/mmwr_metrics.min.js"></script> <script>window.CDC.Policy.External.init();</script> <script> s.pageName=document.title; siteCatalyst.setChannel("MMWR"); siteCatalyst.setLevel1("OS"); siteCatalyst.setLevel2("OSD"); </script> <script> window.shortTitle = "Treatment for Opioid Use Disorder: Population Estimates — United States, 2022"; window.pageOptions = window.pageOptions || {}; window.pageOptions.navigation = window.pageOptions.navigation || { fourthLevelCollapsed: false, showFourthLevel: true }; </script> <script> window.pageOptions.navigation.breadcrumbs = { mode: 'auto', showCurrentPage: false , prefix: [{"text":"CDC","href":"https:\/\/www.cdc.gov\/"}] }; </script> <script> window.CDC.tp4.public.appInit( window.pageOptions ); </script> </body> </html>